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Abstract 
Cardiovascular magnetic resonance (CMR) enables assessment and quantification of morphological and functional 
parameters of the heart, including chamber size and function, diameters of the aorta and pulmonary arteries, flow 
and myocardial relaxation times. Knowledge of reference ranges (“normal values”) for quantitative CMR is crucial to 
interpretation of results and to distinguish normal from disease. Compared to the previous version of this review pub‑
lished in 2015, we present updated and expanded reference values for morphological and functional CMR parameters 
of the cardiovascular system based on the peer‑reviewed literature and current CMR techniques. Further, databases 
and references for deep learning methods are included.
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Background
Cardiovascular magnetic resonance (CMR) provides 
a wealth of information to help distinguish health from 
disease. In addition to non-invasively  defining chamber 
sizes and global function, CMR can also assess regional 
cardiac  function as well as tissue composition (myo-
cardial T1, T2 and T2* relaxation time). Advantages of 
quantitative evaluation of CMR images are objective dif-
ferentiation between pathology and normal conditions, 
grading of disease severity, monitoring changes during 
therapy and evaluating prognosis [1].
Knowledge of the range of normal structure and func-
tion is required to interpret abnormal cardiac conditions. 
Thus, the aim of this review is to provide reference inter-
vals (“normal values”) for morphological and functional 
CMR parameters of the cardiovascular system based on 
a systematic review of the literature using current CMR 
techniques and sequences.
Since the initial publication of the “normal value 
review” in 2015 [1], new research related to CMR refer-
ence values have been published and are now integrated 
in this update. Previous topics were expanded with new 
sections including morphological and functional param-
eters in athletes, myocardial T2 mapping, myocardial 
perfusion, left-ventricular (LV) trabeculation and nor-
mal dimensions of the pulmonary arteries in adults and 
children. Further, feature tracking is increasingly used to 
assess myocardial strain and reference intervals are now 
available for that technology. Deep learning methods are 
rapidly being incorporated into clinical software analysis 
packages [2, 3]. These new analytic methods are expected 
to accelerate quantification of myocardial function from 
CMR images. To date, reference ranges based on cohorts 
of healthy subjects using deep learning methods have not 
been presented. However due to the potential importance 
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of this topic, we present algorithms and major references 
related to CMR on these methods.
Methods
A literature search was performed in PubMed to identify 
publications of CMR reference intervals for each sec-
tion. When feasible (discussed further below), we sought 
to provide weighted means calculated based on these 
published normal values in healthy individuals. General 
criteria used for inclusion of data in this review are as 
follows:
a) Sample size of at least 40 subjects. 40 subjects is 
accepted as the smallest sample size that allows 
calculation of reference ranges using a parametric 
method for data with a Gaussian distribution [4]. In 
some circumstances, separate reference ranges need 
to be provided by gender. In that case, the sample 
size of included studies were at least a minimum of 
40 subjects per gender. Exceptions to sample size of 
40 subjects per group were made for clinically rele-
vant parameters where no publication was available 
with sufficient sample size for certain parameters. 
However, reference ranges based on a smaller sample 
size are of limited validity and should be applied with 
caution.
b) Only values of “healthy” reference cohorts were 
included. In particular, reference cohorts that 
included subjects with a disease or condition known 
to affect the measured parameter (e.g. hypertension 
and diabetes) were excluded. For publications that 
described population statistics (e.g., the MESA study, 
UK Biobank), we used data only from subgroups of 
individuals without risk factors or conditions known 
to affect the CMR parameter. In cases where the 
original manuscript did not provide sufficient infor-
mation to allow upper and lower limits to be calcu-
lated, authors were contacted for clarification.
c) If two or more publications were determined to refer 
to the same healthy reference cohort, the values of 
the cohort were included only once.
Manuscripts were then excluded from consideration as 
follows: (a) obsolescent CMR technique, (b) missing data 
that were not provided by the authors of the original pub-
lication on request and/ or (c) insufficient or inconsistent 
description of methods and/or (d) methods of analysis 
that were not consistent with current Society for Cardio-
vascular Magnetic Resonance (SCMR) guidelines [5] as 
of the time of this review.
Technical factors such as sequence parameters are rele-
vant for CMR, and these factors are provided in relation-
ship to the reference values. In addition, factors related 
to post processing will affect the CMR analysis and these 
factors are also described. Finally, when available,  the 
relationship of demographic factors (e.g. age, gender, 
and ethnicity) to reference values are described in each 
section.
Statistical methods
Statistical analyses were performed with R for statistical 
computing (version 3.5, R Core Team, Vienna, Austria). 
Results from multiple studies reporting normal values 
for the same CMR parameters were combined using a 
random effects meta-analysis model as implemented by 
the metamean function in the meta library in R. This 
produced a weighted, pooled estimate of the population 
mean of the CMR parameters in the combined studies. 
Upper and lower limits of normal values were calculated 
as ± 2SDp, where SDp is the pooled standard deviation 
calculated from the standard deviations reported in each 
study. Mean values and limits of normal values were 
“rounded up” to avoid excess digits beyond the measure-
ment capability of CMR.
Left ventricular dimensions and functions 
in the adult
CMR acquisition parameters
The primary method used to assess the LV is bal-
anced  steady-state free precession (bSSFP) technique 
at 1.5 or 3  T CMR (Table  1). bSSFP technique yields 
improved blood-myocardial contrast compared to its 
predecessor, fast gradient echo (FGRE) sequence.
CMR analysis methods
Papillary muscle mass has been shown to signifi-
cantly affect LV volumes and mass [6–8]. No uniformly 
accepted convention has been used for analyzing trabec-
ulation and papillary muscle mass. Post-processing rec-
ommendations by the SCMR [9] stipulate that papillary 
muscles should either be consistently included in the LV 
volume or in the LV mass, but not in both. Tables of nor-
mal values should specify the status of the papillary mus-
cles in the CMR analysis.
The majority of published articles used semi-automatic 
software for analysis of LV function and structure [10–
16]. Short-axis images are most commonly analyzed on a 
per-slice basis, deriving LV mass and volume by applying 
the Simpson’s method (“stack of disks”) [17]. An exam-
ple of LV contouring is shown in Fig. 1. Automated CMR 
analysis facilitated by machine learning is rapidly making 
inroads in LV volume and mass quantification [3]. The 
primary focus of early manuscripts has been on agree-
ment between manual and automatic contouring [2]. 
However, to date, CMR variables for healthy cohorts have 
not been reported using machine learning methods.
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Measurements of LV diameter obtained on cine 
bSSFP images at diastole and systole on a 4 chamber 
view and short axis view are shown in Fig. 2.
Demographic parameters
Gender is independently related to ventricular volumes 
and mass. Absolute and normalized volumes decrease 
Table 1 References, normal adult left ventricular volumes, function and dimensions
n number of study subjects, bSSFP balanced steady‑state free precession, LV left ventricle
a Mean ± SD (age‑range not provided in original publication)
b 6 subjects > 80 years included
First author, year CMR technique n, male:female Age range (years)
Hudsmith, 2005 [22] 1.5 T, short axis bSSFP, papillary muscles included in LV mass 63:45 21–68
Maceira, 2006 [10] 1.5 T, short axis bSSFP, papillary muscles included in LV mass 60:60 20–80
Chang, 2012 [23] 1.5 T, short axis bSSFP, papillary muscles included in LV volume 64:60 20–70
Macedo, 2013 [24] 1.5 T, short axis bSSFP, papillary muscles included in LV mass 54:53 20–80
Yeon, 2015 [25] 1.5 T, short axis bSSFP, papillary muscles included in LV volume 512:340 (61 ± 9)a
Le, 2016 [11] 3 T, short axis bSSFP, papillary muscles included in LV mass 91:89 20–69
Le Ven, 2016 [14] 1.5 T, Short axis bSSFP, papillary muscles included in LV mass 196:238 18–36
Lei, 2017 [15] 3 T, short axis bSSFP, papillary muscles included in LV volume 60:60 23–83
Petersen, 2017 [16] 1.5 T, short axis bSSFP, papillary muscles included in LV volume 368:432 45–74
Bentatou, 2018 [12] 1.5 T, short axis bSSFP, papillary muscles included in LV mass 70:70 20–69
Buelow, 2018 [13] 1.5 T, short axis bSSFP, papillary muscles included in LV mass 291:326 20–80b
Liu, 2018 [26] 1.5 T, short axis bSSFP, papillary muscles included in LV mass 50:50 20–70
Fig. 1 Contouring of the left ventricle (LV) and right ventricle (RV). Note that LV papillary muscle mass has been isolated and added to LV mass. RV 
papillary muscles and trabeculations were included in the RV volume
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in relationship to age in adults [10] in a continuous man-
ner. For convenience, both average, and values per age 
decile are given in Tables 2, 3, 4 and 5 based on the peer-
reviewed literature.
Studies included in this review
Multiple studies have presented cohorts of normal indi-
viduals for determining normal LV dimensions . For the 
purpose of this review, only cohorts of 40 or more nor-
mal subjects stratified by gender using bSSFP CMR 
technique at 1.5 or 3 T have been included. In addition, 
a full description of the subject cohort (including the 
analysis methods used), age and gender of subjects was 
required to be included for this review. Two studies [18, 
19] included papillary muscles in LV volume except if 
directly attached to the LV wall, in which case they were 
included in LV mass (LVM) instead. Since this approach 
was inconsistent with post-processing recommended 
by SCMR [9] and other manuscripts on the topic, both 
studies were excluded from the current analysis. Data at 
1.5 and 3  T is now available for normal subjects using 
bSSFP short axis imaging. Since it has been shown that 
parameters of LV volumes and function do not vary by 
field strength, calculation of the weighted means of 
these parameters include studies performed at 1.5 T and 
3 T [20]. Information on ethnicity in relationship to LV 
parameters is not available for the majority of papers 
reporting the bSSFP technique and is therefore not 
reported in this review. However, small differences in LV 
parameters by ethnicity have been reported in the Multi-
ethnic Study of Atherosclerosis (MESA) study; for fur-
ther information on the magnitude of such differences, 
the reader is referred to the work by Natori S et al. [21].
Normal adult values for LV dimensions and func-
tions according to those studies that consistently 
included papillary muscles in the LVM are presented in 
Fig. 2 Measurements of LV diameters obtained on cine bSSFP images during diastole (a, b) and systole (c, d) on the 4 chamber view (a, c) and 
short axis view (b, d). The longitudinal diameter of the LV was measured on the 4 chamber view as the distance between the mitral valve plane and 
the LV apex (a, c). On the 4 chamber view the transverse diameter was defined as the distance between the septum and the lateral wall at the basal 
level [18]. On the short axis view the transverse diameter was obtained at the level of the basal papillary muscles (b, d) [15]
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Tables 2, 3, 4, whereas those that consistently included 
papillary muscles in the LV volume are presented in 
Table  5. For parameters with sufficient sample size, 
values are also presented per age decile (Tables 3, 4).
Additional left ventricular function parameters
In addition to left ventricular ejection fraction (LVEF), 
Maceira et  al. have provided additional functional 
parameters that may be useful in some settings [10]. 
These are summarized in Table  6. For diastolic func-
tion, the derivative of the time/volume filling curve 
expresses the peak filling rate (PFR). Both early (E) 
and active (A) transmitral filling rates are provided. In 
addition, longitudinal atrioventricular plane descent 
(AVPD) and sphericity index (volume observed/vol-
ume of sphere using long axis as diameter) at end dias-
tole and end systole are given. These latter parameters 
are not routinely used for clinical diagnosis. A number 
of publications have also reported LV end-diastolic 
and end-systolic diameters by CMR; these parameters 
are summarized in Table 7.
Right ventricular dimensions and functions 
in the adult
CMR acquisition parameters
For measurement of right ventricular (RV) volumes, a 
stack of cine bSSFP images is acquired either in the short 
axis plane or transaxial plane [9].
CMR analysis methods
Similar to the LV, analysis of the RV is usually performed 
on a per slice basis by manual contouring of the endo-
cardial and epicardial borders. Volumes are calculated 
based on the Simpson’s method [17]. The RV volumes 
and mass are significantly affected by inclusion or exclu-
sion of trabeculations and papillary muscles [27, 28]. 
For manual contouring, inclusion of trabeculations and 
papillary muscles as part of the RV volume will achieve 
higher reproducibility [9, 27, 28]. However, semiauto-
matic software is increasingly used for volumetric analy-
sis, enabling automatic delineation of papillary muscles 
[29]. Therefore, normal values for both methods are pro-
vided. An example for RV contouring is shown in Fig. 1. 
Table 2 Left ventricular parameters in  the  adult for  men and  women (ages 18–83), papillary muscles included in  left 
ventricular mass
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LL lower limit, UL upper limit, LV left 
ventricular, EDV end‑diastolic volume, ESV end‑systolic volume, SV stroke volume, EF ejection fraction, LVM left ventricular mass, CO cardiac output, CI cardiac index, 
BSA body surface area
a Pooled weighted values from references [10, 11, 14, 22, 24]
b Pooled weighted values from references [10–14, 22, 24, 26]
c Pooled weighted values from references [10, 11, 14, 22]
d Pooled weighted values from references [10, 11, 13, 14, 22]
e Pooled weighted values from references [10, 11, 13, 14, 22, 24, 26]
f Values from reference [11]
g Pooled weighted values from references [11, 14]
h Calculated as  meanp ± 2*SDp
Parameter Men Women
n Meanp SDp LL–UL
h n Meanp SDp LL–UL
h
LVEDV (ml)a 464 155 30 95–215 485 123 22 78–167
LVEDV/BSA (ml/m2)b 875 79 15 50–108 931 73 12 50–96
LVESV (ml)a 464 55 15 25–85 485 43 11 21–64
LVESV/BSA (ml/m2)b 875 29 9 11–47 931 25 7 10–40
LVSV (ml)c 410 103 21 61–145 432 83 16 52–114
LVSV/BSA (ml/m2)d 701 52 10 33–72 758 49 8 33–64
LVEF (%)b 875 64 8 49–79 931 66 7 52–79
LVM (g)a 464 121 28 66–176 485 83 21 41–125
LVM/BSA (g/m2)e 805 62 11 39–85 861 49 10 30–68
LVCO (l/min)f 91 5.6 1.1 3.4–7.8 89 4.5 0.9 2.7–6.3
LVCI (l/min/m2)f 91 3.0 0.6 1.8–4.2 89 2.9 0.5 1.9–3.9
LVM/LVEDV (g/ml)g 287 0.7 0.1 0.4–0.9 327 0.6 0.1 0.3–0.8
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Detailed recommendations for RV acquisitions and post 
processing have been published [9].
Demographic parameters
RV mass and volumes are dependent on body surface 
area (BSA) [14, 29]. Absolute and RV volumes indexed by 
BSA are significantly larger in males compared to females 
[11, 14, 16, 18, 22, 29]. Further, RV volumes decrease with 
greater age [11, 14, 16, 18, 22, 29].
Studies included in this review
Criteria regarding study inclusion are identical com-
pared to the  LV. Nine studies based on bSSFP imaging 
were included (Table 8). In one study, papillary muscles 
were included as part of the RV mass and excluded from 
the RV volume [29] with results presented for men and 
women in Table  9. In the remaining eight studies, the 
papillary muscles were included as part of the RV cavity 
volume rather than included in the RV mass [11, 14–16, 
18, 22–24] with pooled weighted mean values presented 
for men and women (Table 10). For a subset of three of 
these studies [18, 23, 24], for parameters with a sufficient 
sample size pooled weighted mean values are presented 
based on age deciles between 20 and 59 years of age for 
both men (Table 11) and women (Table 12).
Additional RV function parameters
Similar to the LV, Maceira et al. have provided additional 
functional parameters, including early and active peak 
filling rate and the longitudinal AVPD, that may have rel-
evance to specific applications and can be found in the 
original publication [29].
Left atrial dimensions and functions in the adult
CMR acquisition parameters
There is limited consensus in the literature about how 
to measure left atrial  (LA) volume. The most common 
methods to measure LA volume are the modified Simp-
son’s method (analogous to that used to measure LV and 
RV volumes) and the biplane area-length method [30]. 
Dedicated 3-dimensional modeling software has also 
been employed [31].
In the Simpson’s method, a stack of cine bSSFP images 
either in the SAx, the horizontal long axis or transverse 
view, is required. For 3-dimensional modeling a stack of 
SAx images has been used [31]. Evaluation by the biplane 
area-length method is based on a 2 and 4 chamber view 
[11, 16, 32–34].
LA longitudinal and transverse diameters and area 
have been measured on 2, 3, and 4 chamber cine bSSFP 
images [31, 33, 35] (Fig. 3).
Table 5 Left ventricular parameters in  the  adult for  men and  women (ages 16–83), papillary muscles included in  left 
ventricular volume
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LV left ventricular, EDV end‑diastolic 
volume, ESV end‑systolic volume, SV stroke volume, EF ejection fraction, LVM left ventricular mass, CO cardiac output, CI cardiac index, BSA body surface area
a Pooled weighted values from references [15, 16, 19, 23, 25]
b Pooled weighted values from references [15, 16, 18, 19, 23, 25]
c Pooled weighted values from references [16, 18, 19, 23, 25]
d Pooled weighted values from references [15, 23, 25]
e Pooled weighted values from references [23, 25]
f Pooled weighted values from references [16, 25]
g Calculated as  meanp ± 2*SDp
Parameter Men Women
n Meanp SDp LL–UL
g n Meanp SDp LL–UL
g
LVEDV (ml)a 832 145 31 83–207 1064 112 21 70–155
LVEDV/BSA (ml/m2)b 832 77 15 47–107 1064 69 12 45–93
LVESV (ml)a 832 53 18 19–88 1064 39 12 15–64
LVESV/BSA (ml/m2)b 832 29 9 11–47 1064 24 7 10–38
LVSV (ml)a 832 91 18 55–127 1064 73 13 47–99
LVSV/BSA (ml/m2)c 772 48 9 30–66 1004 45 7 30–59
LVEF (%)b 832 63 6 51–76 1064 66 7 52–79
LVM (g)a 832 105 24 57–152 1064 73 15 43–103
LVM/BSA (g/m2)b 832 56 10 36–75 1064 45 7 30–59
LVCO (l/min)d 464 6.1 1.1 3.9–8.3 632 4.9 1.0 3.0–6.9
LVCI (l/min/m2)e 404 3.2 0.6 2.1–4.3 572 2.9 0.5 1.9–4.0
LVM/LVEDV (g/ml)f 708 0.7 0.2 0.3–1.2 944 0.7 0.1 0.4–1.0
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Table 6 Functional and geometric parameters of the normal left ventricle in the adult, from reference [10]
n number of study subjects, SD standard deviation, LL lower limit, UL upper limit, BSA body surface area, PFR peak filling rate, E early, A active, AVPD atrioventricular 
plane descent
a Calculated as mean ± 2*SD
b Pooled weighted mean and SD calculated from references [10, 18] with n = 195 men and n = 233 women.
Parameter Men (n = 60) Women (n = 60)
Mean SD LL–ULa Mean SD LL–ULa
PFRE (ml/s) 527 140 247–807 477 146 185–769
PFRE /BSA (ml/m2) 270 70 130–410 279 81 117–441
PFRE/EDV (/s) 3.4 0.7 2.0–4.8 3.8 0.8 2.2–5.4
PFRA (ml/s) 373 82 209–537 283 69 145–421
PFRA/BSA (ml/m2) 193 44 105–281 168 44 80–256
PFRA/EDV (/s) 2.6 0.6 1.4–3.8 2.3 0.5 1.3–3.3
PFRE/PFRA 1.4 0.3 0.8–2.0 1.7 0.3 1.1–2.3
Septal AVPD (mm) 15 4 7–23 14 3 8–20
Septal AVPD /long length (%) 15 3 9–21 16 4 8–24
Lateral AVPD (mm) 18 4 10–26 17 3 11–23
Lateral AVPD /long length (%) 17 3 11–23 19 3 13–25
Sphericity index,  diastoleb 0.31 0.07 0.20–0.48 0.34 0.07 0.20–0.48
Sphericity index, systole 0.20 0.05 0.1–0.3 0.23 0.07 0.09–0.37
Table 7 Left ventricular diameters in the adult for men and women, bSSFP technique
bSSFP balanced steady‑state free precession, n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard 
deviation, LL lower limit, UL upper limit, LV left ventricular, 4Ch 4 chamber view, SAx short axis
a Pooled weighted values from references [18, 24]
b Pooled weighted values from references [15, 25]
c Values from reference [24]
d Values from reference [15]
e Calculated as  meanp ± 2*SDp
Parameter Men Women
n Meanp SDp LL–UL
e n Meanp SDp LL–UL
e
LV end‑diastolic diameter 4Ch (mm)a 227 52 5 42–62 188 49 5 39–59
LV end‑diastolic diameter SAx (mm)b 400 53 5 44–62 572 49 4 41–57
LV end‑systolic diameter 4Ch (mm)c 54 32 3 26–38 53 28 6 16–40
LV end‑systolic diameter SAx (mm)d 60 34 3 28–40 60 31 4 23–39
Table 8 References, normal right ventricular volumes, function and dimensions in the adult
n number of study subjects, bSSFP balancedsteady‑state free precession, RV right ventricular
First author, year CMR technique n, male:female Age range (years)
Hudsmith, 2005 [22] 1.5 T, short axis bSSFP, papillary muscles included in RV volume 63:45 21–68
Maceira, 2006 [29] 1.5 T, short axis bSSFP, papillary muscles included in RV mass 60:60 20–80
Chang, 2012 [23] 1.5 T, short axis bSSFP, papillary muscles included in RV volume 64:60 20–70
Macedo, 2013 [24] 1.5 T, short axis bSSFP, papillary muscles included in RV volume 54:53 20–80
Le Ven, 2015 [14] 1.5 T, short axis bSSFP, papillary muscles included in RV volume 196:238 18–36
Lei, 2016 [15] 3 T, short axis bSSFP, papillary muscles included in RV volume 60:60 23–83
Le, 2016 [11] 3 T, short axis bSSFP, papillary muscles included in RV volume 91:89 20–69
Aquaro, 2017 [18] 1.5 T, short axis bSSFP, papillary muscles included in RV volume 173:135 16– > 60
Petersen, 2017 [16] 1.5 T, short axis bSSFP, papillary muscles included in RV volume 368:432 45–74
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CMR analysis methods
In many studies the LA appendage has been included as 
part of the LA volume and pulmonary veins are excluded 
[14, 31], but the practice of excluding both structures 
from the  LA volume is increasingly gaining acceptance 
[11, 16, 32, 34].
The maximal LA volume is achieved during ventricu-
lar systole. In a cine acquisition, the maximum volume 
image can be defined as last image immediately before 
opening of the mitral valve. Accordingly the minimal LA 
volume image can be defined as the first image after clo-
sure of the mitral valve [36].
Table 9 Right ventricular parameters in the adult for men and women (ages 20–79), papillary muscles included in right 
ventricular mass, from reference [29]
n number of study subjects, SD standard deviation, LL lower limit, UL upper limit, RV right ventricular, EDV end‑diastolic volume, ESV end‑systolic volume, SV stroke 
volume, EF ejection fraction, RVM right ventricular mass, BSA body surface area
a Calculated as mean ± 2*SD
Parameter Men (n = 60) Women (n = 60)
Mean SD LL–ULa Mean SD LL–ULa
RVEDV (ml) 163 27 109–217 127 24 79–175
RVEDV/BSA (ml/m2) 83 13 58–109 74 12 51–97
RVESV (ml) 57 17 23–91 44 15 13–75
RVESV/BSA (ml/m2) 29 9 12–46 26 8 9–42
RVSV (ml) 106 18 71–141 83 13 56–110
RVSV/BSA (ml/m2) 54 8 38–71 48 7 35–61
RVEF (%) 66 7 51–80 66 7 52–80
RVM (g) 66 15 37–95 48 11 26–71
RVM/BSA (g/m2) 34 7 20–48 28 6 16–40
Table 10 Right ventricular parameters in the adult for men and women (ages 20–83), papillary muscles included in right 
ventricular volume
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LL lower limit, UL upper limit, RV 
right ventricular, EDV end‑diastolic volume, ESV end‑systolic volume, SV stroke volume, EF ejection fraction, RVM right ventricular mass, CO cardiac output, CI cardiac 
index, BSA body surface area
a Pooled weighted values from references [11, 14–16, 22–24]
b Pooled weighted values from references [11, 14–16, 18, 22–24]
c Pooled weighted values from references [11, 14–16, 22, 23]
d Pooled weighted values from references [11, 14, 16, 18, 22, 23]
e Pooled weighted values from references [22, 24]
f Pooled weighted values from references [11, 23]
g Calculated as  meanp ± 2*SDp
Parameter Men Women
n Meanp SDp LL–ULg n Meanp SDp LL–ULg
RVEDV (ml)a 896 166 39 87–244 977 122 27 68–176
RVEDV/BSA (ml/m2)b 1069 88 17 53–123 1112 76 14 48–104
RVESV (ml)a 896 73 22 29–117 977 50 15 20–80
RVESV/BSA (ml/m2)b 1069 38 11 17–59 1112 30 9 13–48
RVSV (ml)c 842 95 26 43–146 924 74 18 39–109
RVSV/BSA (ml/m2)d 955 52 12 28–75 999 48 9 29–66
RVEF (%)b 1069 57 8 42–72 1112 60 7 46–74
RVM (g)e 117 36 9 17–54 98 30 9 13–48
RVM/BSA (g/m2)e 117 19 4 10–28 98 17 5 7–28
RVCO (l/min)f 155 5.6 1.4 2.8–8.3 149 4.4 1.0 2.4–6.4
RVCI (l/min/m2)f 155 3.0 0.7 1.5–4.5 149 2.8 0.6 1.6–4.0
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Demographic parameters
Body surface area (BSA) has been shown to have a 
significant independent influence on LA volume and 
most diameters [31]. Per Sievers et al. [35], age was not 
an independent predictor of LA maximal volume or 
diameter in normal individuals. Men have a larger max-
imal LA volume compared to women [31, 35].
Studies included in this review
There are nine publications for reference values of the 
adult LA (volume and/or diameter and/or area) based 
Table 11 Right ventricular parameters for  adult men by  age group, papillary muscles included in  right ventricular 
volume
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LL lower limit, UL upper limit, RV 
right ventricular, EDV end‑diastolic volume, ESV end‑systolic volume, SV stroke volume, EF ejection fraction, BSA body surface area
a Pooled weighted values from references [18, 23, 24]
b Pooled weighted values from references [18, 23]
c Calculated as  meanp ± 2*SDp
Parameter 20–29 years 30–39 years 40–49 years 50–59 years
n Meanp ± SDp (LL–UL)c n Meanp ± SDp (LL–UL)c n Meanp ± SDp (LL–UL)c n Meanp ± SDp (LL–UL)*
RVEDV/BSA (ml/m2)a 50 94 ± 15 (63–124) 55 83 ± 13 (57–109) 49 81 ± 16 (50–112) 55 80 ± 16 (48–111)
RVESV/BSA (ml/m2)a 50 44 ± 11 (23–66) 55 38 ± 8 (22–53) 49 34 ± 8 (18–49) 55 35 ± 10 (16–54)
RVSV/BSA (ml/m2)b 40 51 ± 13 (26–77) 43 46 ± 10 (27–65) 40 44 ± 11 (23–65) 40 51 ± 13 (24–78)
RVEF (%)a 50 52 ± 8 (36–69) 55 55 ± 7 (41–68) 49 57 ± 8 (40–73) 55 57 ± 8 (41–74)
Table 12 Right ventricular parameters for  adult women by  age group, papillary muscles included in  right ventricular 
volume
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LL lower limit, UL upper limit, RV 
right ventricular, EDV end‑diastolic volume, ESV end‑systolic volume, SV stroke volume, EF ejection fraction, BSA body surface area
a Pooled weighted values from references [18, 23, 24]
b Pooled weighted values from references [18, 23]
c Calculated as  meanp ± 2*SDp
Parameter 20–29 years 30–39 years 40–49 years 50–59 years
n Meanp ± SDp (LL–UL)c n Meanp ± SDp (LL–UL)c n Meanp ± SDp (LL–UL)c n Meanp ± SDp (LL–UL)*
RVEDV/BSA (ml/m2) a 47 78 ± 12 (55–101) 51 76 ± 12 (51–100) 46 74 ± 14 (46–102) 46 69 ± 13 (42–95)
RVESV/BSA (ml/m2) a 47 33 ± 12 (10–56) 51 31 ± 8 (15–48) 46 29 ± 8 (13–45) 46 28 ± 8 (11–44)
RVSV/BSA (ml/m2)b 37 46 ± 9 (28–63) 33 45 ± 12 (22–69) 35 47 ± 11 (24–69) 37 42 ± 10 (22–62)
RVEF (%)a 47 56 ± 11 (34–78) 51 58 ± 9 (39–77) 46 60 ± 8 (44–76) 46 61 ± 8 (44–78)
Fig. 3 Measurement of left atrial area (A2Ch, A4Ch, A3C), longitudinal (L2Ch, L4Ch), transverse (T2Ch, T4Ch) and anteroposterior (APD) diameters 
on the 2‑, 4‑ and 3‑chamber views according to reference [31]
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on bSSFP imaging with sufficient sample size (n > 40) 
and these are reported in Table 13. Four of these publi-
cations used the biplane area-length method, one used 
the Simpson’s method, one used both, one used a 3D 
modeling technique and the remainder measured diam-
eters or areas. Publications reporting population-based 
cohort data rather than true normal data have been 
excluded from the current analysis as have publications 
that incompletely describe the measurement method 
used [22] or the manner in which pulmonary veins/LA 
appendage were handled. Normal values for  LA volumes 
and function are presented in Table 14, and normal val-
ues for LA diameters in Table 15.
Right atrial dimensions and functions in the adult
CMR acquisition parameters
There is no consensus in the literature regarding acquisi-
tion and measurement method for the right atrium (RA). 
Published methods for RA volume include the modified 
Simpson’s method, the biplane area-length method and 
3D-modeling [23, 24, 37]. For Simpson’s method and 
3D modeling, a stack of cine bSSFP images in the SAx 
view are analyzed. For the biplane area-length method, 
a 4-chamber view and a RV 2-chamber view are utilized 
[33] (Fig. 4).
CMR analysis methods
The inferior and superior vena cava are excluded from 
the RA volume but there is variability in the inclusion 
[14, 37] or exclusion [33] of the RA appendage.
The maximal RA volume is achieved during ventricular 
systole and can be defined as the last cine image before 
opening of the tricuspid valve. The minimal RA volume 
can be defined as the first cine image after closure of the 
tricuspid valve.
Demographic parameters
Maceira et  al. demonstrated the relationship of most 
RA parameters to BSA, but there was no influence of 
age on atrial parameters and no influence of gender on 
atrial volumes [37]. Other studies have demonstrated an 
influence of gender [14, 33] and age [11, 33] on some RA 
parameters. In the study by LeVen et al. gender was inde-
pendently associated with RA end-diastolic volume and 
RA end-systolic volume with men having greater values 
compared to women [14]. In the study by Li et al. the lon-
gitudinal RA diameter measured in the 2 chamber and 4 
chamber view indexed to BSA and the indexed transverse 
diameter measured on the 4 chamber view were greater 
in women than in men [33]. Further, the RA volume 
indexed to BSA was larger in males than in females [33]. 
Le et  al. found a week correlation between the RA area 
indexed to BSA with age [11].
Studies included in this review
There are five publications with reference values for the 
RA based on bSSFP imaging with sufficient sample size 
to be included [11, 14, 18, 33, 37] (Table  16). Pooled 
weighted mean values for RA volumes and function 
are provided in Table  17 using the biplane area-length 
method (RA appendage excluded) or Simpson’s method 
(either RA appendage included or excluded) for men and 
women. Pooled weighted mean values for RA areas and 
diameters are provided in Table 18 for men and women.
Table 13 References, normal left atrial volumes, function and dimensions in the adult
n number of study subjects, bSSFP balanced steady‑state free precession, 3D 3‑dimensional
a Mean ± SD (age‑range not provided in original publication)
First author, year CMR technique n, male:female Age range (years)
Sievers, 2005 [35] 1.5 T, 2, 3 and 4 chamber bSSFP; measurement of diameters 59:52 25–73
Maceira, 2010 [31] 1.5 T, short axis, 2, 3 and 4 chamber bSSFP; 3D modeling and measurement of area and 
diameters; atrial appendage included, pulmonary veins excluded (for volume analysis)
60:60 20–80
Le, 2016 [11] 3 T, 2 and 4 chamber bSSFP; quantification of volume; biplane area‑length method; atrial 
appendage and pulmonary veins excluded
91:89 20–69
Le Ven, 2016 [14] 1.5 T, short axis bSSFP; quantification of volume and function; Simpson’s method; atrial 
appendage included, pulmonary veins excluded
195:239 18–36
Aquaro, 2017 [18] 1.5 T, 4 chamber bSSFP; measurement of area 173:135 16– > 60
Li, 2017 [33] 3 T, short axis, 2, 3 and 4 chamber bSSFP; measurement of volume, function (biplane area‑
length and Simpson’s method atrial appendage excluded) and diameter
66:69 23–83
Petersen, 2017 [16] 1.5 T, 2 and 4 chamber bSSFP; quantification of volume and function; biplane area‑length 
method; atrial appendage and pulmonary veins excluded
371:433 45–74
Zemrak, 2017 [34] 1.5 T, 2 and 4 chamber bSSFP; quantification of volume; biplane area‑length method; atrial 
appendage and pulmonary veins excluded
109:174 (65 ± 9)a
Funk, 2018 [32] 1.5 T and 3 T, 2 and 4 chamber bSSFP; quantification of volume and function; biplane area‑
length method; atrial appendage and pulmonary veins excluded
105:77 19–76
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Additional RA function parameters
Reference ranges for parameters characterizing RA func-
tion, including the reservoir, conduit and pump function, 
can be found in a separate publication by Maceira et al. 
[38].
Left and right ventricular dimensions and function 
in children
The presentation of normal values in children is different 
than in the adult population due to continuous changes 
in body weight and height as a function of age. Normal 
data in children are frequently presented in percentiles 
and/or z-scores (standard deviation score). Z-scores are 
given as
z - value = (measurement−mean of the population)/(standard deviation of the mean of the population).
Even though previous studies [39–41] have reported 
a linear correlation between ventricular volumes and 
BSA in children, there is increasing evidence that the 
assumption of a simple linear or exponential rela-
tionship between somatic growth and age may not be 
correct. Moreover the relationship between cardiac 
growth and body growth is still not clearly understood 
and may vary along age in the developing child [42, 
43].
The construction of reference curves using the 
Lamda-Mu-Sigma (LMS) method is a different way of 
creating normalized growth percentile curves. In this 
approach after a power transformation skewness of 
the data can be transformed into normality and trends 
Table 14 Left atrial volumes and function in the adult for men and women, SSFP technique
n number of study subjects included in the weighted mean values, bSSFP balanced steady‑state free precession, meanp pooled weighted mean, SDp pooled standard 
deviation, LL lower limit, UL upper limit, Max. maximal, Min. minimal, LA left atrial, BSA body surface area
a Pooled weighted values from references [11, 16, 32–34]
b Pooled weighted values from references [22, 32, 33]
c Pooled weighted values from references [32, 33]
d Pooled weighted values from references [16, 32]
e Values from reference [16]
f Pooled weighted values from references [16, 22, 32, 33]
g Values from reference [33]
h Pooled weighted values from references [14, 31]
i Values from reference [14]
j Calculated as  meanp ± 2*SDp
Method Parameter Men Women
n Meanp SDp LL–UL
j n Meanp SDp LL–UL
j
Biplane area‑length method; LA appendage excluded Max. LA volume (ml)a 734 72 20 31–112 841 64 18 28–100
Max. LA volume/BSA (ml/m2)a 734 38 11 17–59 841 39 11 17–61
Min. LA volume (ml)b 171 25 10 6–44 146 22 8 7–38
Min. LA volume/BSA (ml/m2)c 171 14 5 3–24 146 13 5 4–23
LA stroke volume (ml)d 468 44 12 21–67 509 42 10 21–62
LA stroke volume/BSA (ml/m2)e 363 22 6 10–34 432 22 6 10–34
LA ejection fraction (%)f 534 62 8 46–77 578 63 8 48–78
Simpson’s method; LA appendage excluded Max. LA volume (ml)g 66 70 15 40–99 69 66 13 39–93
Max. LA volume/BSA (ml/m2)g 66 41 8 24–57 69 44 8 28–60
Min. LA volume (ml)g 66 32 9 15–50 69 28 7 15–42
Min. LA volume/BSA (ml/m2)g 66 19 5 9–28 69 19 4 11–27
LA ejection fraction (%)g 66 54 8 38–70 69 57 6 45–69
Simpson’s method; LA appendage included Max. LA volume (ml)h 256 78 18 42–115 298 66 14 37–94
Max. LA volume/BSA (ml/m2)h 256 40 8 25–56 298 39 7 25–53
Min. LA volume (ml)i 196 32 9 14–50 238 24 7 10–38
Min. LA volume/BSA (ml/m2)i 196 17 4 9–25 238 15 4 7–23
LA stroke volume (ml)i 196 47 13 21–73 238 39 10 19–59
LA stroke volume/BSA (ml/m2)i 196 24 6 12–36 238 24 5 14–34
LA ejection fraction (%)i 196 59 8 43–75 238 61 7 47–75
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are summarized in a smooth curve (L); trends in the 
mean (M) and coefficient of variation (S) are similarly 
smoothed. LMS curves are easy to use in daily practice 
and can account for nonlinear relationships between 
body and cardiac size and age.
The LMS method is highly efficient to obtain normal-
ity in small datasets, for instance in the group of young 
children. Thus, even extreme values (small children) can 
be so converted into exact standard deviation scores [44].
Demographic parameters
The largest cohort of normal data on ventricular size and 
function in paediatric patients using the bSSFP sequence 
refers to a population of 141 healthy children collected 
in three European reference centers. All subjects were 
Caucasian and included 68 boys and 73 girls. Age dis-
tribution, body size and heart rate were equal between 
genders. Only 12/141 children were younger than 6 years 
[45].
Boys had larger ventricles than girls [45]. LVEF was 
found to be slightly higher in boys (67% vs 65%; p 0.01), 
but not for the RV [45]. Gender differences are more 
marked in older children, indicating that gender is more 
important after puberty and in adulthood.
Studies included in this review
Table  19 shows studies meeting inclusion criteria. The 
reference values for the LV and RV presented in the study 
by van der Ven [45] have been pooled from three previ-
ous studies [39–41], that have been reported separately 
in the previous version of our review [1]. Data are pre-
sented in percentile curves referred to age by using the 
LMS Method (Figs. 5, 6).
CMR analysis methods
For calculation of reference values from reference 
[45], the original bSSFP images (short axis) have been 
re-analysed by manual segmentation by one operator, 
after consensus on the segmentation rules was estab-
lished within the group. These followed the standards 
proposed by SCMR [46], except for the trabeculations 
of the RV, required for calculating the RV mass. In the 
RV major trabeculae were included in the myocardium 
if they were visualized as being connected to the RV 
Table 15 Left atrial diameter and area in the adult for men and women, bSSFP technique
n number of study subjects included in the weighted mean values, bSSFP balanced steady‑state free precession, meanp pooled weighted mean, SDp pooled standard 
deviation, LL lower limit, UL upper limit, Max. maximal, LA left atrial, 2Ch 2 chamber view, 3Ch 3 chamber view, 4Ch 4 chamber view, BSA body surface area
a Values from reference [31]
b Pooled weighted values from references [18, 31]
c Pooled weighted values from references [31, 33, 35]
d Pooled weighted values from references [31, 33]
e Values from reference [33]
f Calculated as  meanp ± 2*SDp
Parameter Men Women
n Meanp SDp LL–UL
f n Meanp SDp LL–UL
f
Max. LA area 2Ch  (cm2)a 60 21 5 12–30 60 19 5 10–28
Max. LA area 2Ch/BSA  (cm2/m2)a 60 11 2 6–16 60 11 2 6–16
Max. LA area 3Ch  (cm2)a 60 19 4 12–26 60 17 4 10–24
Max. LA area 3Ch/BSA  (cm2/m2)a 60 10 2 6–14 60 10 2 6–14
Max. LA area 4Ch  (cm2)b 233 23 5 13–32 173 21 4 13–29
Max. LA area 4Ch/BSA  (cm2/m2)b 233 12 2 7–16 195 12 2 8–15
Max. LA longitudinal diameter 2Ch (cm)c 185 4.9 0.7 3.5–6.2 181 4.6 0.7 3.3–5.9
Max. LA longitudinal diameter 2Ch/BSA (cm/m2)c 185 2.6 0.5 1.6–3.6 181 2.8 0.6 1.6–3.9
Max. LA transverse diameter 2Ch (cm)d 126 4.4 0.6 3.2–5.6 129 4.3 0.5 3.3–5.2
Max. LA transverse diameter 2Ch/BSA (cm/m2)d 126 2.4 0.3 1.7–3.0 129 2.7 0.3 2.2–3.2
Max. LA longitudinal diameter 3Ch (cm)e 66 5.5 0.6 4.2–6.8 69 5.4 0.7 4.0–6.7
Max. LA longitudinal diameter 3Ch/BSA (cm/m2)e 66 3.2 0.4 2.4–4.0 69 3.6 0.5 2.7–4.6
Max. LA antero‑posterior diameter 3Ch (cm)c 185 3.0 0.5 2.0–4.0 181 3.0 0.5 2.0–4.0
Max. LA antero‑posterior diameter 3Ch/BSA (cm/m2)c 185 1.6 0.3 1.0–2.2 181 1.8 0.4 1.1–2.5
Max. LA longitudinal diameter 4Ch (cm)d 126 5.8 0.6 4.6–7.1 129 5.5 0.6 4.2–6.8
Max. LA longitudinal diameter 4Ch/BSA (cm/m2)d 126 3.2 0.4 2.3–4.1 129 3.5 0.5 2.5–4.4
Max. LA transverse diameter 4Ch (cm)c 185 4.3 0.5 3.3–5.3 181 4.1 0.5 3.1–5.1
Max. LA transverse diameter 4Ch/BSA (cm/m2)c 185 2.2 0.3 1.6–2.9 181 2.5 0.4 1.8–3.2
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wall in more than 2 adjacent slices. Trabecular islands 
not connected to the wall were included in the blood 
pool [45].
Left and right atrial dimensions and function 
in children
CMR acquisition parameters
 LA  and RA dimensions and function were evaluated 
using bSSFP technique in a single publication [47], 
(Table  19). Measurements were obtained on a stack 
of transverse cine bSSFP images with a slice thickness 
between 5 and 6 mm without interslice gap [47].
CMR analysis methods
In [47], the pulmonary veins, the superior and inferior 
vena cava and the coronary sinus were excluded from 
the LA and RA volume, respectively, while the atrial 
appendages were included in the volume of the respec-
tive atrium. The maximal atrial volume was measured at 
Fig. 4 Measurement of right atrial (RA) parameters according to [37]. Areas and diameters were measured in atrial diastole (maximal size of the left 
atrium) on the 2‑chamber (top row) and 4‑chamber (bottom row) views. In B), longitudinal diameter (L) is obtained from the posterior wall of the RA 
to the center of the tricuspid plane, and transverse diameter (T) is obtained perpendicular to the longitudinal diameter, at the mid level of the RA. C 
shows measurements of the area for both views including the RA appendage
Table 16 References, normal right atrial volumes, function and dimensions in the adult
n number of study subject, bSSFP balanced steady‑state free precession, RV right ventricular
First author, year CMR technique n, male:female Age range (years)
Maceira, 2013 [37] 1.5 T, short axis, RV 2 chamber and 4 chamber bSSFP, 3D modeling and measurement of 
area and diameters, atrial appendage included for volume analysis
60:60 20–80
Le Ven, 2015 [14] 1.5 T, short axis bSSFP, quantification of volume and function (Simpson’s method), atrial 
appendage included
196:238 25–73
Le, 2016 [11] 3.0 T, 4 chamber bSSFP, measurement of area 91:89 20–69
Aquaro, 2017 [18] 1.5 T, 4 chamber bSSFP, measurement of area 173:135 16– > 60
Li, 2017 [33] 3.0 T, Short axis, RV 2 chamber and 4 chamber bSSFP, measurement of diameter, volume 
and function (biplane area‑length and Simpson’s method), atrial appendage excluded
66:69 23–83
Page 16 of 63Kawel‑Boehm et al. J Cardiovasc Magn Reson           (2020) 22:87 
Table 17 Right atrial volumes and function in the adult for men and women
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LL lower limit, UL upper limit, Max. 
maximal, Min. minimal, RA right atrial, BSA body surface area
a Values from reference [33]
b Pooled weighted values from references [14, 37]
c Values from reference [14]
d Calculated as  meanp ± 2*SDp
Method Parameter Men Women
N Meanp SDp LL–UL
d n Meanp SDp LL–UL
d
Biplane area‑length method; RA appendage excluded Max. RA volume (ml)a 66 65 20 24–105 69 53 14 24–81
Max. RA volume/BSA (ml/m2)a 66 38 12 15–61 69 35 10 16–54
Min. RA volume (ml)a 66 32 12 9–55 69 23 7 9–37
Min. RA volume/BSA (ml/m2)a 66 19 7 5–32 69 15 5 6–24
RA ejection fraction (%)a 66 50 9 32–68 69 56 9 38–74
Simpson’s method; RA appendage excluded Max. RA volume (ml)a 66 89 22 46–132 69 77 16 45–108
Max. RA volume/BSA (ml/m2)a 66 52 12 28–76 69 51 10 31–71
Min. RA volume (ml)a 66 46 16 14–79 69 35 9 17–53
Min. RA volume/BSA (ml/m2)a 66 27 9 9–45 69 23 6 12–35
RA ejection fraction (%)a 66 49 10 29–69 69 54 9 36–72
Simpson’s method; RA appendage included Max. RA volume (ml)b 256 108 25 59–158 298 85 18 49–122
Max. RA volume/BSA (ml/m2)b 256 56 12 32–79 298 50 10 31–69
Min. RA volume (ml)c 196 50 17 16–84 238 33 11 11–55
Min. RA volume/BSA (ml/m2)c 196 26 8 10–42 238 20 6 8–32
RA stroke volume (ml)c 196 58 16 26–90 238 47 12 23–71
RA stroke volume/BSA (ml/m2)c 196 30 8 14–46 238 28 7 14–42
RA ejection fraction (%)c 196 54 10 34–74 238 59 9 41–77
Table 18 Right atrial diameter and area in the adult for men and women, bSSFP technique
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LL lower limit, UL upper limit, Max. 
maximal, RA right atrial, 2Ch 2 chamber view, 3Ch 3 chamber view, 4Ch 4 chamber view, BSA body surface area
a Values from reference [37]
b Pooled weighted values from references [11, 18, 37]
c Pooled weighted values from references [33, 37]
d Calculated as  meanp ± 2*SDp
Parameter Men Women
n Meanp SDp LL–UL
d n Meanp SDp LL–UL
d
Max. RA area 2Ch  (cm2)a 60 23 4 15–31 60 21 4 13–29
Max. RA area 2Ch/BSA  (cm2/m2)a 60 12 2 7–17 60 12 2 7–17
Max. RA area 4Ch  (cm2)b 324 21 4 13–30 284 19 3 12–26
Max. RA area 4Ch/BSA  (cm2/m2)b 324 11 2 7–15 284 12 2 8–15
Max. RA longitudinal diameter 2Ch (cm)c 126 5.5 0.6 4.2–6.7 129 5.1 0.6 3.9–6.3
Max. RA longitudinal diameter 2Ch/BSA (cm/m2)c 126 3.0 0.4 2.3–3.7 129 3.2 0.4 2.3–4.1
Max. RA transverse diameter 2Ch (cm)c 126 4.2 0.9 2.4–6.0 129 4.1 0.9 2.4–5.9
Max. RA transverse diameter 2Ch/BSA (cm/m2)c 126 2.3 0.5 1.3–3.3 129 2.6 0.6 1.5–3.7
Max. RA longitudinal diameter 4Ch (cm)c 126 5.3 0.6 4.0–6.6 129 5.1 0.6 4.0–6.3
Max. RA longitudinal diameter 4Ch/BSA (cm/m2)c 126 2.9 0.4 2.2–3.7 129 3.2 0.4 2.4–4.0
Max. RA transverse diameter 4Ch (cm)c 126 4.8 0.6 3.7–5.9 129 4.3 0.6 3.2–5.4
Max. RA transverse diameter 4Ch/BSA (cm/m2)c 126 2.6 0.3 2.1–3.2 129 2.7 0.3 2.0–3.4
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ventricular end-systole and the minimal atrial volume at 
ventricular end-diastole.
Demographic parameters
LA  and RA volumes show an increase with age with a 
plateau after the age of 14 for girls only. Absolute and 
indexed volumes have been shown to be significantly 
greater for boys compared to girls (except for the indexed 
maximal volumes for both atria) [47].
Studies included in this review
Sarikouch et al. evaluated atrial parameters of 115 healthy 
children (Table  19) [47] using bSSFP imaging. Data is 
presented as L, M, S values to enable calculation of the 
standard deviation score and in percentiles (Tables  20, 
21).
Cardiac chamber size in the athlete
CMR analysis methods
Methodologic considerations for CMR analysis are the 
same as for the non-athletes heart as described in the 
sections above. In both studies included in this review, 
papillary muscles and trabeculations were included in the 
ventricular volumes and excluded from LV and RV mass.
Demographic parameters
Following the Mitchell classification, sports can be char-
acterized as being high or low in dynamic (endurance, 
isotonic) versus static (strength/resistance, isometric) 
training and performance components [48]. Athletic 
competition can therefore be primarily (a) endurance 
(e.g. long distance running, swimming), (b) combined 
(e.g. rowers, cyclists) or (c) strength (e.g. body building 
and weight training). There are insufficient numbers of 
study subjects available in the literature to establish nor-
mative values for the strength category of athletes [49].
Cardiac chamber sizes may vary depending on the 
extent of exercise and training. One approach to classi-
fication is 9–18 h of training per week (regular athletes) 
vs > 18 h training per week (elite athletes) [50]. Adaptive 
changes to exercise are greater with higher exercise/
training level [49].
Luijkx found a balanced increase of LV and RV cham-
ber  volume in relationship in the athlete heart [51]; a 
large meta-analysis of the literature had a similar con-
clusion [49]. RV and LV systolic function is commonly 
characterized by ejection fraction, but this parameter is 
known to show the most variation between observers. 
Nevertheless, RVEF and LVEF are > 50% in reports of the 
athlete’s heart by CMR [48].
The RV chamber  volumes are greater in the athletes 
heart than in normal individuals [51]. The athlete’s 
RV volumes may exceed CMR criteria for abnormal-
ity in arrhythmogenic right ventricular cardiomyopathy 
(ARVC). However, RVEF is in the normal range of non-
athletes even in the athlete heart (i.e. > 50%) whereas 
RVEF is abnormally low (≤ 45%) in ARVC.
Studies included in this review
After elimination of redundant publications using the 
same study population and publications with > 40 ath-
letes, there is one publication with data on the ath-
lete’s heart by Prakken et al. (Table 22) [50]. This study 
was performed at 1.5  T and has sufficient descrip-
tion of CMR analysis technique to enable comparison 
(Tables  23, 24). Papillary muscles and trabeculation 
were included in ventricular volumes and excluded from 
myocardial mass. The study by Prakken et al. [50] speci-
fied levels of training (regular athletes 9–18  h/week; 
elite athletes > 18  h per week), both endurance and 
combined types of athletic participation were included. 
In contrast, Tahir et al. [52] identified athletes as those 
competing in triathlons (classified as ‘combined’ sport 
activity and training for more than 10 h per week) with-
out further subcategorization. Although a smaller size 
cohort, the study by Tahir et al. may also be useful for 
the interested reader [52].
Finally, one publication [49] presents a meta-analysis of 
the literature in an attempt to provide reference ranges. 
For the purposes of this review, that meta-analysis 
Table 19 References, normal dimensions of cardiac chambers in children
n number of study subjects, bSSFP balanced steady‑state free precession, LV left ventricular, RV right ventricular
First author, year CMR technique n, male:female Age range (years)
van der Ven, 2019 [45] 1.5 T, short axis bSSFP; dimensions of LV and RV; papillary mus‑
cles included in LV mass; RV mass measured at end‑systole, 
major trabeculae included in RV mass when connected to 
the ventricular wall, trabeculae not connected to the wall 
included in RV volume
68:73  < 1–18
Sarikouch, 2011 [47] 1.5 T, axial bSSFP; pulmonary veins, superior and inferior 
vena cava and coronary sinus excluded, atrial appendages 
included from/in left and right atrial volume, respectively
56:59 4–20
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Fig. 5 Reference curves for LV dimensions and function in children, reprinted with permission from reference [45]. Curves for boys are displayed in 
blue on the left, curves for girls are shown in pink on the right. Reference lines show the 3rd, 10th, 90th and 97th percentile. LV left ventricle, ED end 
diastolic, ES end systolic, SV stroke volume
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Fig. 6 Reference curves for RV dimensions and function in children, reprinted with permission from reference [45]. Curves for boys are displayed in 
blue on the left, curves for girls are shown in pink on the right. Reference lines show the 3rd, 10th, 90th and 97th percentile. LV left ventricle, ED end 
diastolic, ES end systolic, SV stroke volume
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Table 20 Normal left atrial and right atrial volume in boys; LMS parameters to calculate z-scores and percentiles relative 
to age according to reference [47]
LMS: L = Lambda (skewness of the distribution), M = Mu (median), S = Sigma (variance)
Standard deviation score (SDS) = [(X/M)L – 1]/(L*S), where X is the measured atrial volume in ml/m2 and L, M and S are the values interpolated for the child’s age; 
lower and upper limits correspond to a score of ‑2 and 2 and to the 3rd and 97th percentile, respectively
a Age in years
Agea Left atrium Right atrium
LMS-parameters Percentiles (ml/m2) LMS-parameters Percentiles (ml/m2)
L M S P3 P50 P97 L M S P3 P50 P97
6 1.378 36.715 0.263 14 37 55 1.806 33.342 0.191 20 39 68
7 1.378 38.610 0.246 17 39 56 1.806 48.385 0.203 22 43 71
8 1.378 40.291 0.229 20 40 57 1.806 51.247 0.205 24 47 73
9 1.378 41.762 0.212 22 42 58 1.806 51.742 0.205 26 49 74
10 1.378 43.375 0.197 25 43 59 1.806 52.579 0.204 28 52 75
11 1.378 45.120 0.183 27 45 61 1.806 54.891 0.200 30 54 76
12 1.378 46.671 0.171 29 47 62 1.806 56.348 0.197 32 57 77
13 1.378 47.784 0.161 31 48 62 1.806 57.830 0.193 33 59 78
14 1.378 48.331 0.152 33 48 62 1.806 59.473 0.188 34 61 79
15 1.378 48.581 0.142 34 49 62 1.806 61.042 0.181 35 63 80
16 1.378 49.112 0.131 36 49 61 1.806 63.114 0.171 37 65 81
17 1.378 50.353 0.120 38 50 62 1.806 64.322 0.161 38 67 82
18 1.378 52.583 0.111 40 53 64 1.806 66.227 0.145 40 69 84
19 1.378 55.860 0.103 44 56 67 1.806 72.157 0.110 43 71 85
20 1.378 59.928 0.097 48 60 71 1.806 77.498 0.064 45 72 86
Table 21 Normal left atrial and right atrial volume in girls; LMS parameters to calculate z-scores and percentiles relative 
to age according to reference [47]
LMS, L = Lambda (skewness of the distribution), M = Mu (median), S = Sigma (variance)
Standard deviation score (SDS) = [(X/M)L – 1] / (L*S), where X is the measured atrial volume in ml/m2 and L, M and S are the values interpolated for the child’s age; 
lower and upper limits correspond to a score of ‑2 and 2 and to the 3rd and 97th percentile, respectively
a Age in years
Agea Left atrium Right atrium
LMS-parameters Percentiles (ml/m2) LMS-parameters Percentiles (ml/m2)
L M S P3 P50 P97 L M S P3 P50 P97
4 − 1.100 37.566 0.248 22 34 44 0.889 47.196 0.328 18 47 79
5 − 0.956 38.333 0.242 23 36 46 0.774 47.386 0.318 20 47 80
6 − 0.717 39.568 0.234 25 39 50 0.587 47.733 0.302 23 48 80
7 − 0.478 40.739 0.225 26 41 53 0.421 48.181 0.284 25 48 80
8 − 0.239 41.934 0.217 28 43 55 0.266 48.837 0.265 28 49 80
9 0.000 43.072 0.208 28 44 56 0.106 49.868 0.244 30 50 80
10 0.239 43.953 0.199 28 44 56 ‑0.033 51.098 0.221 33 51 80
11 0.478 44.548 0.191 29 44 57 ‑0.071 52.283 0.197 35 52 78
12 0.717 45.080 0.182 29 45 58 0.029 53.388 0.175 38 53 76
13 0.956 45.636 0.173 30 45 59 0.262 54.329 0.157 39 54 73
14 1.195 46.118 0.165 30 46 60 0.595 55.205 0.147 40 55 72
15 1.434 46.070 0.156 30 47 60 0.991 55.815 0.145 40 56 72
16 1.673 45.343 0.148 30 46 59 1.419 56.153 0.148 38 56 72
17 1.912 44.258 0.139 29 44 57 1.852 56.470 0.155 36 56 72
18 2.151 43.116 0.130 28 42 55 2.276 57.000 0.164 31 57 73
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Table 22 Reference, cardiac chamber size in the athlete
n number of study subjects, bSSFP balanced steady‑state free precession
First author, year CMR technique n, gender, sports intensity Age range 
(years)
Prakken, 2010 [50] 1.5 T, short axis bSSFP, papillary muscles included in LV volume 83, male, regular athletes (9–18 h/week) 18–39
46, male, elite athletes (> 18 h/week) 18–39
60, female, regular athletes (9–18 h/week) 18–39
33, female, elite athletes (> 18 h/week) 18–39
56, male, non‑athletes 18–39
58, female, non‑athletes 18–39
Table 23 Left ventricular parameters for adult athletes (papillary muscles included in LV volume) according to reference 
[50]
SD standard deviation, LL lower limit, UL upper limit, n number of study subjects, LV left ventricular, EDV end‑diastolic volume, ESV end‑systolic volume, EF ejection 
fraction, LVM left ventricular mass, max. IVS maximal thickness of the interventricular septum, BSA body surface area
a 9–18 h sports activity/week
b  > 18 h sports activity/week
c Calculated as mean ± 2*SD
Parameter Non-athletes [mean ± SD (LL–UL)c] Regular  athletesa [mean ± SD (LL–
UL)c]
Elite  athletesb [mean ± SD (LL–UL)c]
Men (n = 56) Women (n = 58) Men (n = 83) Women (n = 60) Men (n = 46) Women (n = 33)
LVEDV (ml) 201 ± 33 (135–267) 156 ± 22 (112–200) 250 ± 32 (186–314) 194 ± 27 (140–248) 261 ± 39 (183–339) 199 ± 31 (137–261)
LVEDV/BSA (ml/m2) 101 ± 15 (71–131) 90 ± 11 (68–112) 123 ± 13 (97–149) 107 ± 14 (79–135) 129 ± 17 (95–163) 107 ± 14 (79–135)
LVESV (ml) 87 ± 19 (49–125) 65 ± 13 (39–91) 108 ± 20 (68–148) 86 ± 15 (56–116) 117 ± 24 (69–165) 85 ± 20 (45–125)
LVESV/BSA (ml/m2) 43 ± 10 (23–63) 37 ± 7 (23–51) 53 ± 9 (35–71) 48 ± 8 (32–64) 58 ± 11 (36–80) 46 ± 11 (24–68)
LVM (g) 95 ± 20 (55–135) 60 ± 11 (38–82) 125 ± 22 (81–169) 84 ± 17 (50–118) 139 ± 28 (83–195) 92 ± 15 (62–122)
LVM/BSA (g/m2) 48 ± 9 (30–66) 34 ± 6 (22–46) 62 ± 11 (40–84) 46 ± 9 (28–64) 69 ± 13 (43–95) 50 ± 8 (34–66)
LVEF (%) 57 ± 6 (45–69) 58 ± 5 (48–68) 57 ± 5 (47–67) 55 ± 4 (47–63) 55 ± 5 (45–65) 58 ± 7 (44–72)
max. IVS (mm) 10 ± 1 (8–12) 5 ± 1 (3–7) 11 ± 1 (9–13) 9 ± 1 (7–11) 11 ± 1 (9–13) 9 ± 1 (7–11)
Table 24 Right ventricular parameters for  adult athletes (papillary muscles included in  right ventricular volume) 
according to reference [50]
SD standard deviation, LL lower limit, UL upper limit, n number of study subjects, RV right ventricular, EDV end‑diastolic volume, ESV end‑systolic volume, EF ejection 
fraction, RVM right ventricular mass, BSA body surface area
a 9–18 h sports activity/week
b  > 18 h sports activity/week
c Calculated as mean ± 2*SD
Parameter Non-athletes [mean ± SD (LL–UL)c] Regular  athletesa [mean ± SD (LL–
UL)c]
Elite  athletesb [mean ± SD (LL–UL)c]
Men (n = 56) Women (n = 58) Men (n = 83) Women (n = 60) Men (n = 46) Women (n = 33)
RVEDV (ml) 223 ± 40 (143–303) 166 ± 23 (120–212) 277 ± 36 (205–349) 209 ± 29 (151–267) 291 ± 48 (195–387) 219 ± 35 (149–289)
RVEDV/BSA (ml/m2) 111 ± 18 (75–147) 96 ± 12 (72–120) 136 ± 16 (104–168) 115 ± 15 (85–145) 144 ± 20 (104–184) 118 ± 17 (84–152)
RVESV (ml) 108 ± 24 (60–156) 75 ± 13 (49–101) 135 ± 25 (85–185) 102 ± 17 (68–136) 148 ± 30 (88–208) 103 ± 24 (55–151)
RVESV/BSA (ml/m2) 54 ± 12 (30–78) 43 ± 7 (29–57) 66 ± 12 (42–90) 57 ± 9 (39–75) 73 ± 13 (47–99) 56 ± 13 (30–82)
RVM (g) 23 ± 5 (13–33) 18 ± 4 (10–26) 29 ± 6 (17–41) 23 ± 4 (15–31) 30 ± 6 (18–42) 25 ± 5 (15–35)
RVM/BSA (g/m2) 12 ± 2 (8–16) 10 ± 2 (6–14) 14 ± 3 (8–20) 13 ± 2 (9–17) 15 ± 2 (11–19) 14 ± 3 (8–20)
RVEF (%) 52 ± 5 (42–62) 55 ± 5 (45–65) 51 ± 4 (43–59) 51 ± 4 (43–59) 50 ± 4 (42–58) 53 ± 7 (39–67)
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included multiple publications with overlapping/redun-
dant study populations, small sample size (< 40 subjects 
in most studies) and did not take into account marked 
differences in analysis methods noted above. While 
useful to display overall trends in the literature for the 
athletes heart, the aforementioned meta-analysis was 
therefore not included in this study.
Normal thickness of the compact left ventricular 
myocardium in adults
CMR acquisition parameters
Normal values of the thickness of the compact LV myo-
cardium have been shown to vary by type of pulse 
sequence (FGRE versus bSSFP) [53, 54]. For the purposes 
of this review, only bSSFP normal values are shown.
CMR analysis methods
In this review LV myocardial thickness refers to measure-
ments of the thickness of the compact LV myocardium 
obtained at end-diastole (Fig.  7). Papillary muscles and 
trabeculations are excluded from measurement of the 
thickness of the compact LV myocardium.
Measures of LV myocardial thickness vary by the plane 
of acquisition (SAx versus long axis) [55]. Measurements 
obtained on long axis images at the basal and mid-cavity 
level have been shown to be significantly greater com-
pared to measurements on corresponding SAx images, 
whereas measurements obtained at the apical level of 
long axis images are significantly lower compared to SAx 
images.
Demographic parameters
LV myocardial thickness is greater in men than women 
[14, 18, 25, 55, 56]. There are also small differences in 
LV myocardial thickness in relationship to ethnicity 
and body size, but these variations are not likely to have 
clinical significance [55]. Regarding age, one study of 120 
healthy subjects age 20–80 years reported an increase in 
myocardial thickness with age—starting after the fourth 
decade [56]. In the study by Kawel el al. of 300 normal 
individuals without hypertension, smoking history or dia-
betes, there was no statistically significant difference in 
LV myocardial thickness with age [55].
Studies included in this review
There are five publications of a systematic analysis of LV 
myocardial thickness based on bSSFP imaging at 1.5  T 
with a sample size > 40 healthy subjects per gender and 
a detailed description of the measurement technique 
(Table  25). Dawson et  al. and Le Ven et  al. published 
measurements for all 16 segments (apex excluded) 
obtained on short axis images (Table 26) [14, 56]. Kawel 
et al. published normal values of LV myocardial thickness 
for long and SAx imaging for 12 and 16 segments, respec-
tively (Tables  26, 27) [55]. Yeon et  al. and Aquaro et  al. 
obtained measurements for only two myocardial seg-
ments on SAx images (Table 26) [18, 25].
Table 25 References, normal thickness of the compact left ventricular myocardium in the adult
n number of study subjects, bSSFP balanced steady‑state free precession
a Age range not provided in original publication
First author, year CMR technique n, male:female Age range (years)
Dawson, 2011 [56] 1.5 T, short axis bSSFP, 16 segments (apex excluded) 60:60 20–80
Kawel, 2012 [55] 1.5 T, short (16 segments, apex excluded) and long axis (12 segments) bSSFP 131:169 54–91
Le Ven, 2015 [14] 1.5 T, short axis bSSFP; 16 segments (apex excluded) 196:238 18–36
Yeon, 2015 [25] 1.5 T, short axis bSSFP; 2 segments (basal inferolateral and anteroseptal) 340:512 (men: 61 ± 8; women: 62 ± 9)a
Aquaro, 2017 [18] 1.5 T, short axis bSSFP; 2 segments (basal anterior septum, basal inferolateral 
wall)
173:135 15–80
(See figure on next page.)
Fig. 7 Example of measurement approaches for LV trabeculation. a End‑diastolic thickness (in mm) of trabeculation according to the methodology 
in [56]: 3 slices representing base, mid and apex were selected from within the entire LV stack; trabeculated myocardial thickness was measured 
per slice; segment 17 excluded from analysis; authors do not clarify whether papillary muscles had been included or excluded from the trabecular 
measurement—in this reproduction we have excluded papillary muscles. b Maximal non‑compacted (NC, red lines)/compacted (c, orange lines) 
wall thickness ratio according to the methodology in [61]: papillary muscles that were clearly observed as compact tubular structures were not 
included in the measurements; measurements in mm are shown in white and the maximal NC/C parameter highlighted in blue. c Trabeculation 
mass according to the methodology in [12]: the endocardial contour (red) was manually drawn; the trabecular contour (orange) was automatically 
segmented and papillary muscles (blue) that were included in the compact myocardial mass, were semi‑automatically segmented; all slices of the 
LV short axis stack were analyzed. d Fractal dimension according to the methodology in [60]: using a semi‑automatic level‑set segmentation with 
bias field correction; all slices of the LV short axis stack are analyzed except for the apical slice; fractal dimensions per slice reported in the top right 
corner
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Table 26 Normal left ventricular myocardial thickness (in mm) in  the  adult measured on  short  axis images for  men 
and women
Segments: 1: basal anterior, 2: basal anteroseptal, 3: basal inferoseptal, 4: basal inferior, 5: basal inferolateral, 6: basal anterolateral, 7: mid anterior, 8: mid anteroseptal, 
9: mid inferoseptal, 10: mid inferior, 11: mid inferolateral, 12: mid anterolateral, 13: apical anterior, 14: apical septal, 15: apical inferior, 16: apical lateral
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LL lower limits, UL upper limits
a Pooled weighted values from references [14, 55, 56]
b Pooled weighted values from references [14, 18, 25, 55, 56]
c Calculated as  meanp ± 2*SDp
Level Segment Men Women
n Meanp SDp LL–UL
c n Meanp SDp LL–UL
c
Basal 1a 387 7.8 1.3 5–10 467 6.4 1.1 4–9
2b 900 9.0 1.4 6–12 1114 7.6 1.2 5–10
3a 387 8.8 1.2 6–11 467 7.3 1.0 5–9
4a 387 7.9 1.2 6–10 467 6.4 1.0 4–8
5b 900 7.7 1.2 5–10 1114 6.3 1.1 4–9
6a 387 7.5 1.2 5–10 467 6.1 1.0 4–8
Mid‑cavity 7a 387 6.7 1.2 4–9 467 5.6 1.0 4–8
8a 387 7.4 1.3 5–10 467 6.1 1.0 4–8
9a 387 7.9 1.2 6–10 467 6.6 1.0 5–9
10a 387 7.0 1.2 5–9 467 5.8 1.0 4–8
11a 387 6.5 1.4 4–9 467 5.3 1.0 3–7
12a 387 6.6 1.2 4–9 467 5.5 1.1 4–8
Apical 13a 387 6.5 1.2 4–9 467 5.9 1.3 3–9
14a 387 6.8 1.3 4–9 467 5.8 1.1 4–8
15a 387 6.1 1.1 4–8 467 5.2 1.0 3–7
16a 387 6.2 1.1 4–8 467 5.6 1.0 4–8
Table 27 Normal left ventricular myocardial thickness (in mm) in  the  adult measured on  long axis images for  men 
and women according to reference [55]
n number of study subjects, SD standard deviation, LL lower limits, UL upper limits
a Calculated as mean ± 2*SD
Level Region Men (n = 131) Women (n = 169)
Mean SD LL–ULa Mean SD LL–ULa
Basal Anterior 8.2 1.3 6–11 7 1.1 5–9
Inferior 8.2 1.3 6–10 6.7 1.1 5–9
Septal 9.1 1.3 7–12 7.3 1.1 5–10
Lateral 7.6 1.3 5–10 6 1.1 4–8
Mean 8.3 1.0 6–10 6.8 0.9 5–9
Mid‑cavity Anterior 6 1.3 3–9 4.9 1.1 3–7
Inferior 7.7 1.3 5–10 6.5 1.1 4–9
Septal 8.3 1.3 6–11 6.8 1.1 5–9
Lateral 6.6 1.3 4–9 5.3 1.1 3–8
Mean 7.2 1.0 5–9 6 1 4–8
Apical Anterior 5.1 1.3 3–8 4.2 1.1 2–6
Inferior 5.8 1.3 3–8 5 1.1 3–7
Septal 5.8 1.3 3–8 5 1.1 3–7
Lateral 5.5 1.3 3–8 4.6 1.1 2–7
Mean 5.6 1.0 4–8 4.7 0.9 3–7
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Normal values of left ventricular trabeculation
CMR acquisition parameters
CMR methods used to assess LV trabeculation (Table 28) 
are based on the bSSFP technique to leverage on the 
blood-myocardial contrast it provides. The key methods 
are illustrated in Fig. 7.
CMR analysis methods
No uniformly accepted convention has been 
used for analyzing trabeculation. At least seven 
different measurement approaches have been described 
(Table  28). Principally these methods measure trabec-
ulation in the LV either in terms of the trabeculated 
layer’s thickness, mass, volume, or fractal complexity, 
with or without adjusting for the thickness, mass or 
volume of the adjacent compacted myocardium. Tables 
of normal values for trabeculation should specify the 
phase of the cardiac cycle in which measurements were 
taken together with imaging planes used. When report-
ing trabeculation mass, volume or fractal complexity, 
Table 28 References, normal thickness, mass, ratios and  fractal dimension of  the  left ventricular trabeculated (non-
compacted) myocardium in the adult
n number of study subjects, LV left ventricular, bSSFP balanced steady‑state free precession
a Male:female ratio not provided in original publication
b Age range not provided in original publication
First author, year CMR technique n, male:female Age range (years)
Trabeculation thickness (thickness of the trabeculated [non-compacted] LV myocardium)
Dawson, 2011 [56] 1.5 T, short axis bSSFP, maximal thickness per segment at diastole and systole 60:60 20–80
NC/C thickness ratio (thickness of trabeculated [non-compacted] LV myocardium/ thickness of compact LV myocardium)
Dawson, 2011 [56] 1.5 T, short axis bSSFP, NC/C thickness ratio per segment measured manually 
at the “peak of the most prominent trabeculae in each segment” at diastole 
and systole
60:60 20–80
Kawel, 2012 [61] 1.5 T, long axis bSSFP at diastole, maximal NC/C thickness ratio of 12 seg‑
ments
192:175 54–91
Captur, 2013 [59] 1.5 T, long axis bSSFP at diastole, maximal NC/C thickness ratio of 16 seg‑
ments
40 (total)* 18–85
Tizón‑Marcos, 2014 [65] 1.5 T, long‑ and short axis bSSFP, mean NC/C thickness ratio per segment 
measured semi‑automatically by the centerline method (average of 20–30 
chords/segment) at diastole and systole
45:55 18–35
Amzulescu, 2015 [58] 1.5 T and 3 T, long axis bSSFP at diastole, maximal NC/C thickness ratio of 16 
segments
22:26 (60 ± 10)**
André, 2015 [64] 1.5T, long axis bSSFP at diastole,maximal NC/C thickness ratio of16 segments 58:59 20– > 50
Trabeculation mass (mass of the trabeculated [non-compacted] LV myocardium)
Bentatou, 2018 [12] 1.5 T, short axis bSSFP at diastole, papillary muscles and blood between 
trabeculae excluded
70:70 20–69
Trabeculation volume (volume of the trabeculated [non-compacted] LV myocardium)
André, 2015 [64] 1.5 T, short axis bSSFP, blood between trabeculae included, papillary muscles 
excluded
58:59 20– > 50
NC/C mass ratio (mass of trabeculated [non-compacted] LV myocardium/ mass of compact LV myocardium)
Amzulescu, 2015 [58] 1.5 T and 3 T, short axis bSSFP at diastole, mass of trabeculated myocardium 
includes trabeculae and blood between trabeculae, papillary muscles 
excluded from trabeculated and compact mass
22:26 (60 ± 10)b
Bentatou, 2018 [12] 1.5 T, short axis bSSFP at diastole, blood between trabeculae excluded from 
mass of trabeculated myocardium, papillary muscles included in mass of 
compact myocardium
70:70 20–69
NC/TM (mass of trabeculated [non-compacted] LV myocardium/ total LV myocardial mass [trabeculated + compact LV myocardial mass])
Captur, 2013 [59] 1.5 T, short axis bSSFP at diastole, mass of trabeculated myocardium includes 
trabeculae and blood between trabeculae, papillary muscles included in 
mass of compact myocardium
40 (total)a 18–85
Fractal dimension (fractal complexity of LV trabeculated [non-compacted] myocardium)
Captur, 2013 [59] 1.5 T, short axis bSSFP at diastole, papillary muscles included in the endocar‑
dial complexity
51:54 (75 white, 30 black) 18–85
Captur 2015 [62] 1.5 T, short axis bSSFP at diastole, papillary muscles included in the endocar‑
dial complexity
279:325 46–91
Cai, 2017 [66] 3 T, short axis bSSFP at diastole, papillary muscles included in the endocardial 
complexity
91:89 20–69
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tables should specify whether papillary muscles were 
included or excluded in the trabecular assessment. 
Where semi-automated segmentation of trabecular 
contours is undertaken, the type of algorithm used may 
impact subsequent results so the methods must specify 
the algorithm in detail [57].
Table 29 provides normal adult values for thickness of 
the trabeculated LV myocardium, on a segment-by-seg-
ment basis. Table  30 provides normal values for mass 
and volume of trabeculation. Trabeculation mass ratio 
has additionally been reported [12, 58, 59] but meas-
urement heterogeneity across studies, with respect to 
handling of the blood pool between trabeculations and 
inclusion/exclusion of papillary muscles, has led to dif-
fering definitions and no consensus normal values.
Tables  31 and 32 provide normal values for LV tra-
beculation measured as a fractal dimension. Four frac-
tal parameters for quantifying LV trabeculation [59] 
include global LV, maximal basal, maximal mid and 
maximal apical fractal dimension. To derive the global 
LV fractal dimension, the fractal dimensions from each 
slice in the LV stack (Fig. 7d) were averaged; to derive 
local fractal characteristics, the maximal fractal dimen-
sion in the basal, mid and apical thirds of the left ven-
tricle were recorded [59].
Normal values by this approach for global LV and 
maximal apical fractal dimension are presented in 
Table  31. Methodological developments for fractal 
analysis of the left ventricle are ongoing [60].
Demographic parameters
In the largest published reference cohort (n = 323) [61], 
there was no relationship between maximal non-com-
pacted (NC)/compacted (C) wall thickness ratio and age, 
gender, race/ethnicity, height or weight.
For segment-by-segment (whole-heart) NC/C ratio 
[56], there was also no significant difference between gen-
ders, but age-related differences were present: the thick-
ness of the trabeculated myocardium generally increased 
until the 3rd decade and subsequently decreased. This 
trend was significant in the anterior (1, 7, 13) and apical 
inferior segments, but not in the remainder of segments 
[56].
Using the fractal dimension, ethnicity was shown to 
influence LV trabeculation parameters, with greater 
endocardial complexity (i.e. higher fractal dimension) 
demonstrated in healthy blacks as opposed to healthy 
whites, and greater complexity demonstrated in Whites, 
African American and Hispanics compared to Chinese 
Americans [62].
Table 29 Normal thickness of  the  trabeculated (non-
compacted) left ventricular myocardium on  short  axis 
at end-diastole (in mm) in the adult according to [56]
According to the original publication (n = 120), data are presented as mean ± SD 
for normally distributed variables and as median (first, third interquartile ranges) 
for nonparametric variables; Segments: 1 = basal anterior, 2 = basal anteroseptal, 
3 = basal inferoseptal, 4 = basal inferior, 5 = basal inferolateral, 6 = basal 
anterolateral, 7 = mid anterior, 8 = mid anteroseptal, 9 = mid inferoseptal, 
10 = mid inferior, 11 = mid inferolateral, 12 = mid anterolateral, 13 = apical 
anterior, 14 = apical septal, 15 = apical inferior, 16 = apical lateral.
Level Segment Mean (median) SD (IQR)




5 0 0, 3.9
6 0 0, 4.1
Mid‑cavity 7 5.6 2.8
8 0
9 0
10 0 0, 2.1
11 4.2 2.5
12 4.4 2.7
Apical 13 5.6 2.7
14 0
15 0 0, 4.5
16 7.1 2.4
Table 30 Normal values for mass and volume of trabeculated (non-compacted) left ventricular myocardium in the adult 
measured on short axis images
n number of study subjects, SD standard deviation, BSA body surface area
Parameter Technique Men Women
n Mean SD n Mean SD
Trabeculation mass (mass of the trabeculated 
[non‑compacted] LV myocardium) per BSA 
(g/m2) from ref [12]
Papillary muscles and blood 
between trabeculae 
excluded
70 5.4 2.3 70 4.0 2.3
Trabeculation volume (volume of the trabecu‑
lated [non‑compacted] LV myocardium) per 
BSA (ml/m2) from ref [64]
Blood between trabeculae 
included, papillary muscles 
excluded
58 43.1 8.7 59 36.1 5.2
Page 27 of 63Kawel‑Boehm et al. J Cardiovasc Magn Reson           (2020) 22:87  
Studies included in this review
For the purpose of this review, only cohorts of 40 or more 
normal subjects using bSSFP CMR technique have been 
included. Data from population-based studies where 
exclusions for comorbidities was undertaken have also 
been included [61, 62]. The majority of reported normal 
values were derived at 1.5 T although a few 3 T studies 
have also been undertaken (see Table 28). Inclusion cri-
teria for reported tables included a full description of the 
subject cohort (including the analysis methods used), age 
and gender of subjects. One study evaluated elite male 
athletes which was not deemed to be representative of 
the average population and was therefore not included in 
this review [63].
The caliper-based linear measurement of thickness of 
trabeculation [61] has progressively evolved into more 
complex metrics: the maximal NC/C thickness ratio has 
been measured by at least four groups [58, 59, 61, 64] but 
reported normal values were too discordant for calcula-
tion of weighted means in this review (thus not shown in 
Table 29). The inter-study discordance of maximal NC/C 
parameters may stem from the subjective selection by 
readers of the visually most trabeculated segment/s for 
analysis (Fig. 7b). The largest of these studies, which also 
included reproducibility assessment, reported median 
values for normal adult maximal NC/C thickness of 2.2 
[5th and 95th percentile: 1.0, 4.6] [61]. Other studies 
opted for a more systematic segment-by-segment analy-
sis of thickness of trabeculation but still methodologies 
differed: Dawson et al. [56]. measured the maximal thick-
ness of trabeculated myocardium per segment (Fig.  7a), 
whereas Tizon [65] measured the average of 20–30 meas-
urements of the thickness of trabeculation per segment, 
with consequently different results.
Cardiac valves and quantification of flow
CMR acquisition parameters
Prospectively and retrospectively electrocardiogram 
(ECG)-gated phase contrast (PC) CMR sequences are 
widely available. Prospectively-gated sequences use 
arrhythmia rejection and may be performed in a breath 
hold. Retrospectively gated techniques are mainly per-
formed during free-breathing, often with higher spatial 
and temporal resolution compared to the breath hold 
techniques [67]. Four-dimensional flow-sensitive (4D 
Flow) PC CMR techniques have shown promising ini-
tial results, but 2D PC flow techniques remains the most 
commonly used approach in daily clinical practice [68]. 
In addition to PC-CMR, valve planimetry—using ECG-
gated bSSFP CMR—can also be used to estimate stenosis 
or insufficiencies with good correlation to echocardio-
graphic measurements [69].
Measurements of flow are most precise when (a) the 
imaging plane is positioned perpendicular to the vessel of 
interest and (b) the velocity encoded gradient echo  (Venc) 
is encoded in a through plane direction [70]. The slice 
thickness should be ≤ 7 mm to minimize partial volume 
effects. Compared to aortic or pulmonary artery  flow 
evaluation, quantification of mitral or tricuspid valves is 
more challenging using PC-CMR due to through plane 
motion during the cardiac cycle [71].
The flow encoding velocity  (Venc) should be cho-
sen close to the maximum expected flow velocity of 
the examined vessel for precise measurements. Set-
ting the  Venc below the peak velocity results in aliasing. 
Table 31 Normal values for  the  fractal dimension (FD) 
(unitless) of  left ventricular trabeculation in  the  adult 
for different ethnicities
n number of study subjects, SD standard deviation
a Measured for the apical third of the left ventricle
b Measured for the apical half of the left ventricle
Parameter Ethnicity n Mean SD
Global FD from ref [59] Black 30 1.246 0.005
Maximal apical  FDa from 
ref [59]
Black 30 1.235 0.03
Global FD from ref [59] White 75 1.228 0.002
Maximal apical  FDa from 
ref [59]
White 75 1.253 0.025
Global FD from ref [66] Singaporean Chinese 180 1.205 0.031
Maximal apical  FDb from 
ref [66]
Singaporean Chinese 180 0.278 0.045
Table 32 Normal values for  the  fractal dimension (FD) (unitless) of  left ventricular trabeculation in  the  adult stratified 
by sex and body mass index (BMI) according to reference [62]
n number of study subjects, BMI body mass index, SD standard deviation, Max. maximal
a Measured for the apical half of the left ventricle
Parameter BMI ≥ 30 kg/m2 (mean ± SD) BMI ≥ 25 to < 30 kg/m2 (mean ± SD) BMI < 25 kg/m2 (mean ± SD)
All (n = 163) Men (n = 71) Women 
(n = 92)










1.203 ± 0.06 1.212 ± 0.07 1.196 ± 0.06 1.194 ± 0.06 1.197 ± 0.05 1.190 ± 0.07 1.169 ± 0.07 1.177 ± 0.06 1.162 ± 0.05
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For the normal aorta and main pulmonary artery, maxi-
mum velocities usually do not exceed 150 and 90 cm/s, 
respectively.
Adequate temporal resolution is necessary to avoid 
temporal flow averaging, especially for the evaluation of 
short, fast, and turbulent jets within a vessel (e.g. aortic 
stenosis). For clinical routine, 25–30 ms temporal resolu-
tion is sufficient. The minimum required spatial resolu-
tion is less than one third of the vessel diameter to avoid 
partial volume effects with the adjacent vessel wall and 
surrounding stationary tissues for small arteries [70].
CMR analysis methods
For data analysis, dedicated flow software should be used. 
Most of the currently available flow software tools offer 
semi-automatic vessel contouring, which needs to be 
carefully checked by the examiner.
The modified Bernoulli equation (∆P = 4 × Vmax2) is 
commonly used for calculation of pressure gradients 
using PC-CMR across the pulmonary or aortic valve [72, 
73].
Velocity measurements of valvular stenosis with high 
jet velocities may be inaccurate due to (A) partial volume 
effects in case of a small jet width and (B) limited tem-
poral resolution compared to the high velocity of the jet. 
Measurements are further affected by signal loss due to 
the high velocity that may lead to phase shift errors and 
dephasing. Misalignment of the slice relative to the direc-
tion of the jet may also lead to an underestimation of the 
peak velocity [74].
Mitral valve flow velocities and deceleration times can 
be quantified for assessment of LV diastolic function, 
in a manner analogous to that used with transthoracic 
echocardiography (TTE). 2D PC derived trans-mitral 
flow velocities and deceleration times are strongly corre-
lated with TTE derived parameters, but with a systematic 
underestimation [75].
Demographic parameters
To our knowledge, no comprehensive studies have been 
performed to investigate the association between age, 
gender and ethnicity and valvular flow or valve plani-
metry in normal healthy subjects based on PC-CMR. 
Two recent studies using 4D Flow CMR investigated 
the relationship of aortic flow velocity with age and gen-
der, respectively [76, 77]. Callaghan et al. [76] compared 
measurements of mean peak systolic velocity obtained 
in the ascending aorta between 3 age groups and found 
a significant decrease with age. Garcia et al. [77] showed 
the mean aortic valve peak velocity was higher with 
greater age. In the study by Garcia et  al. the differences 
in peak systolic velocity with gender were small and likely 
not clinically relevant [77].
Studies included in this review
There is good agreement between PC-CMR, bSSFP CMR 
planimetry, and echocardiography measurements. Amer-
ican Heart Association (AHA) criteria for grading valve 
stenosis or insufficiency is suggested [78, 79] (Table 33). 
To our knowledge, there is no publication from a large 
study of normal reference values of trans-valvular flow 
and valve planimetry based on PC-CMR measurements.
Mitral valve flow parameters for determination of dias-
tolic LV function are shown in Table 34.
Garcia, et  al. [77] and Callaghan, et  al. [76] have 
reported normal thoracic aorta flow parameters using 4D 
Flow CMR. Amongst other parameters, Garcia obtained 
measurements of peak systolic velocity where the trans-
valvular velocity reaches its maximum during peak sys-
tole (vena contracta region) (Fig.  8a) while Callaghan 
acquired measurement 6 cm proximal from the most cra-
nial point of the aortic arch centerline in the ascending 
aorta (Fig. 8b). Normal values of peak aortic velocity are 
given in Tables 35 and 36.
Normal aortic dimensions in the adult
CMR acquisition parameters
Three-dimensional contrast enhanced CMR angiogra-
phy (CMRA) has gained broad acceptance and is widely 
used for the assessment and follow-up of thoracic aortic 
diameters in the clinical setting. The multi-planar refor-
mation of CMRA images leads to an accurate measure-
ment perpendicular to the lumen of the vessel. However, 
motion caused by pulsation leads to substantial blurring 
of the vessel contour at the level of the aortic root, ham-
pering accurate diameter measurements [81]. The need 
of a contrast injection is another limitation for the use of 
this technique, particularly in patients who need multi-
ple follow up examinations and in population based study 
settings [82]. Alternatively non-contrast techniques such 
as an ECG- and respiratory-gated gadolinium-enhanced 
CMRA or 3D bSSFP sequence can be applied, enabling 
accurate measurements of aortic diameters including 
the aortic root [82]. However, due to the long acquisi-
tion times or lack of sequence availability, these methods 
may not be widely applied [81]. The magnitude image of 
PC CMR has also been used to measure diameters of the 
aorta [83]. Black blood techniques are used for a more 
detailed assessment of the aortic wall [84].
In 2D acquisitions, the imaging plane needs to be 
acquired correctly at the time of the scan; thus, any 
alterations in the imaging plane due to breath-holding or 
patient motion will result in variability of measurements. 
Through plane motion during the cardiac cycle can be 
minimized with ECG gating [82].
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Table 33 Stages of valvular heart disease in the adult. adapted from echocardiography according to references [78, 79]
BSA body surface area
Valve disease Parameter Stage
Progressive Severe
Aortic stenosis Maximum velocity (m/s) Mild: 2.0–2.9
Moderate: 3.0–3.9
Severe: ≥ 4
Very severe: ≥ 5
Low‑flow/low‑
gradient: < 4 m/s 
(at rest)
Orifice area  (cm2)  ≤ 1.0
Orifice area /BSA  (cm2/m2)  ≤ 0.6
Aortic regurgitation Regurgitant volume (ml/beat) Mild: < 30
Moderate: 30–59
 ≥ 60
Regurgitant fraction (%) Mild: < 30
Moderate: 30–49
 ≥ 50
Effective regurgitant orifice  (cm2) Mild: < 0.10
Moderate 0.10–0.29
 ≥ 0.30
Mitral stenosis Transmitral flow velocity (m/s) Increased
Orifice area  (cm2)  > 1.5 Severe: ≤ 1.5
Very severe: ≤ 1.0
Primary mitral regurgitation Regurgitant volume (ml/beat)  < 60  ≥ 60
Regurgitant fraction (%)  < 50  ≥ 50
Effective regurgitant orifice  (cm2)  < 0.40  ≥ 0.40
Secondary mitral regurgitation Regurgitant volume (ml/beat)  < 60  ≥ 60
Regurgitant fraction (%)  < 50  ≥ 50
Effective regurgitant orifice  (cm2)  < 0.40  ≥ 0.40
Pulmonic stenosis Peak velocity (m/s)  > 4
Tricuspid stenosis Orifice area  (cm2)  < 1.0
Table 34 Mitral valve flow for determination of diastolic left ventricular function according to reference [80]
MDT mitral deceleration time, E/A ratio ratio of the mitral early (E) and atrial (A) components of the mitral inflow velocity profile
Parameter Normal Type 1 (Impaired 
relaxation)





MDT (ms) 150–220 Increased Normal Decreased Decreased
E/A ratio 1–2  < 1 1–2  > 2  > 2
Potthast and colleagues compared the diameter of the 
ascending aorta obtained by different CMR sequences 
to ECG-triggered computed tomography  angiogra-
phy  (CTA) as the standard of reference. They reported 
that ECG-gated navigator triggered 3D bSSFP sequence 
showed the best agreement with CTA [82].
CMR analysis methods
Beside the sequence type, imaging plane and cardiac 
phase (systole versus diastole), it is important to identify 
the anatomic locations of diameter measurements of the 
thoracic aorta (Fig. 9).
The sagittal oblique view of the LV outflow tract was 
used for measuring diameter at the level of the aortic 
annulus, the aortic sinus, and the sinotubular junction 
(Fig. 10) [11, 85, 86]. Axial cross sectional images at pre-
defined anatomic levels were used for measuring the 
ascending and descending aorta [86] as well as cusp-
commissure and cusp-cusp diameters at the level of the 
aortic sinus [85] (Fig. 11).
Luminal or outer to outer diameter of the aorta may 
be measured. The current SCMR guidelines on image 
post-processing recommend measurement of the outer 
contour in dilatation while measurements of the inner 
contour should be obtained in the setting of stenosis [9]. 
In the tables below, the method is specified.
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Demographic parameters
In the MESA, a large population based study, the diam-
eter of the ascending aorta has been shown to be larger in 
men compared to women even after adjustment for BSA 
[83]. In a publication by Le et  al., however, the gender 
difference in diameters did not persist after normaliza-
tion to BSA [11].
Several studies have shown an increase in aortic diam-
eter with age [11, 83, 85, 86]. The association of age 
with aortic diameter was more marked in the ascending 
aorta compared to the descending thoracic and abdom-
inal aorta, respectively [87, 88]. Further, age-related 
changes of the geometry of the thoracic aorta have been 
described. Age-related changes include increasing length 
of the ascending aorta and decreasing curvature of the 
aortic arch [89, 90].
In the MESA study, there were small differences in nor-
mal aortic diameter for Chinese and African American 
participants compared to Caucasians. These differences 
were small however relative to measurement error and 
reproducibility and therefore may not be clinically rel-
evant [83].
Studies included in this review
Studies with normal values of aortic diameters based 
on measurements obtained in studies with 40 or more 
healthy subjects per gender have been included in this 
review (Table  37). There are five major publications 
regarding CMR-based measurements of the thoracic 
aorta in adults [11, 83–86]. There is substantial differ-
ence between the studies with respect to CMR sequences 
(cine bSSFP, PC CMRA and 3D-T1-black blood volume 
isotropic turbo spin echo acquisition), acquisition/ meas-
urement plane (cross sectional versus LV outflow tract 
view), measurement technique (luminal versus total 
diameter and area, respectively) and measurement sites 
Fig. 8 Images of a 4D flow sequence illustrating sites of 
measurement of peak systolic velocity. According to reference [77] 
measurements were obtained where the transvalvular velocity 
reaches its maximum during peak systole (vena contracta region) (a). 
In reference [76] peak systolic velocity was obtained in the ascending 
aorta 6 cm proximal from the most cranial point of the aortic arch 
centerline (b)
Table 35 Normal mean peak systolic velocity of  the  ascending aorta by  4D-flow for  different age groups according 
to reference [76]
Measured 6 cm proximal from the most cranial point of the aortic arch centerline (Fig. 8b)
n number of study subjects, SD standard deviation, LL lower limit, UL upper limit
a Calculated as mean ± 2*SD
Parameter 18–33 years 34–60 years  > 60 years
n Mean SD LL–ULa n Mean SD LL–ULa n Mean SD LL–ULa
Velocity (cm/s) 64 66 15 36–96 116 51 13 25–77 67 35 12 11–59
Table 36 Normal mean aortic valve peak velocity by 4D-flow CMR for men and women according to reference [77]
Measured where the transvalvular velocity reaches its maximum during peak systole (Fig. 8a)
n number of study subjects, SD standard deviation, LL lower limit, UL upper limit
a Calculated as mean ± 2*SD
Parameter Men Women
n Mean SD LL–ULa n mean SD LL–ULa
Velocity (m/s) 57 1.3 0.3 0.8–1.8 41 1.2 0.2 0.8–1.6
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of the aorta. Therefore, results of most studies are pre-
sented separately (Tables 38, 39, 40, 41). Details of image 
acquisition and measurement technique of each study 
can be found in Table 37 and are described in the foot-
note of each table.
Weighted means were calculated based on the values of 
the diameter of the aortic root obtained on the 3D bSSFP 
sequence in LVOT view published by Burman, Davis and 
Le (Table 42) [11, 85, 86].
Normal aortic dimensions in children
CMR acquisition parameters
There is currently no consensus regarding the optimal 
CMR sequence to measure aortic diameters and areas 
in children. In three major publications documenting 
aortic dimensions in children (Table 43), measurements 
were obtained with three-dimensional contrast enhanced 
CMRA [91], gradient echo images [92] and phase con-
trast cine images [93].
CMR analysis methods
To minimize errors in measurement of aorta size, mul-
tiplanar reformation should be used to make double-
oblique measurements perpendicular to the centerline of 
the course of the vessel. Kaiser et  al. demonstrated that 
aortic diameter measurements vary slightly based on 
plane orientation, with a mean difference between meas-
urements on cross-sectional and longitudinal images of 
0.16 mm and a coefficient of variability of 2.1% [91].
Aorta measurements should also be made in a consist-
ent manner with respect to the wall of the aorta—outer 
Fig. 9 Sites of measurement of the thoracic aorta. AS aortic sinus, 
STJ sinotubular junction, AA ascending aorta, BCA proximal to 
the origin of the brachiocephalic artery, T1 between the origin of 
the brachiocephalic artery and the left common carotid artery, 
T2 between the origin of the left common carotid artery and the 
left subclavian artery, IR isthmic region, DA descending aorta, D 
thoracoabdominal aorta at the level of the diaphragm
Fig. 10 Measurements of luminal diameters of the aortic annulus 
(a), the aortic sinus (b) and the sinotubular junction (c) obtained on 
a steady‑state free precession left ventricular outflow tract view at 
diastole according to reference [86]
Fig. 11 Cusp‑commissure (continuous lines) and cusp‑cusp 
(dashed‑lines) measurements at the level of the aortic sinus 
according to reference [85]
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wall to outer wall, leading edge to leading edge, or lumi-
nal diameter. Kutty et  al. indicated that in their study 
measurements were made from outer wall to outer wall 
[93]. Kaiser et al. and Voges et al. did not provide details 
on how measurements were made in this regard [91, 92].
Table 37 References, normal aortic diameters, area and wall thickness in adults
n number of study subjects, bSSFP balanced steady‑state free precession, LVOT left ventricular outflow tract, VISTA volume isotropic turbo spin echo acquisition
First author, year CMR technique n, male:female Age range (years)
Burman, 2008 [85] 1.5 T, cine bSSFP, luminal diameter at systole and diastole, average of 3 cusp‑commissure 
and 3 cusp‑cusp diameters, respectively on cross‑sectional images of the aortic sinus and 
diameter of the aortic sinus on the sagittal LVOT plane
60:60 20–80
Davis, 2014 [86] 1.5 T, cine bSSFP, maximal luminal diameter at diastole, diameters calculated based on 
measurements of the area at 3 levels (ascending aorta, proximal and distal descending 
aorta) of the aorta on cross‑sectional images and diameters at 3 levels (annulus, sinus, 
sinotubular junction) of the aortic root measured on the sagittal LVOT plane
208:239 19–70
Turkbey, 2014 [83] 1.5 T, luminal diameter of the ascending aorta measured on the magnitude image of a 
phase contrast sequence
770:842 45–84
Eikendal, 2016 [84] 3 T, fat suppressed 3D‑T1‑black blood VISTA acquired sagittal of the descending aorta, lumi‑
nal and total vessel diameter and area, calculated average diameter, luminal and total 
vessel area, vessel wall area and thickness of the proximal to distal descending aorta after 
manual tracing of the luminal and outer aortic wall on axial reformatted images
59:65 25–35
Le, 2016 [11] 3 T, cine bSSFP, luminal diameter of the aortic annulus, sinus and sinotubular junction at 
diastole measured on the sagittal LVOT plane
91:89 20–69
Table 38 Absolute and indexed (to BSA) normal values of aortic sinus luminal diameters and area for men and women 
at systole and diastole according to [85]
Values obtained as the average of 3 cusp‑commissure and 3 cusp‑cusp diameters, respectively measured on cross‑sectional bSSFP images of the aortic sinus (Fig. 11)
n number of study subjects, SD standard deviation, LL lower limit, UL upper limit, BSA body surface area
a Calculated as mean ± 2*SD
Parameter Men (n = 60) [mean ± SD (LL–UL) a] Women (n = 60) [mean ± SD (LL–UL)a]
Systolic Diastolic Systolic Diastolic
Aortic sinus diameter (cusp‑commissure) (mm) 34 ± 3 (27–40) 32 ± 4 (25–39) 30 ± 3 (25–35) 28 ± 3 (23–34)
Aortic sinus diameter (cusp‑commissure)/BSA (mm/m2) 17 ± 2 (14–20) 16 ± 2 (13–20) 18 ± 2 (14–21) 17 ± 2 (13–20)
Aortic sinus diameter (cusp‑cusp) (mm) 36 ± 4 (28–44) 35 ± 4 (27–43) 32 ± 3 (26–38) 31 ± 3 (24–37)
Aortic sinus diameter (cusp‑cusp)/BSA (mm/m2) 18 ± 2 (14–22) 18 ± 2 (14–22) 19 ± 2 (15–23) 18 ± 2 (14–22)
Aortic sinus area  (cm2) 9.2 ± 2.1 (5.0–13.4) 8.4 ± 2.0 (4.4–12.4) 7.1 ± 1.4 (4.3–9.9) 6.5 ± 1.3 (3.9–9.1)
Aortic sinus area/BSA  (cm2/m2) 4.6 ± 1.0 (2.6–6.6) 4.2 ± 0.9 (2.4–6.0) 4.2 ± 0.8 (2.6–5.8) 3.8 ± 0.8 (2.2–5.4)
Table 39 Normal values of  the  thoracic aortic luminal diameters for  men and  women measured at  diastole on  bSSFP 
images according to [86]
Measurements obtained on cross‑sectional bSSFP images of the aorta
bSSFP balanced steady‑state free precession, n number of study subjects, SD standard deviation, LL lower limit, UL upper limit
a Calculated as mean ± 2*SD
Level Men (n = 208)
Mean ± SD (LL–UL)a
Women (n = 239)
Mean ± SD (LL–UL)a
Ascending aorta diameter (mm) 27 ± 8 (11–42) 26 ± 7 (11–40)
Proximal descending aorta diameter (mm) 21 ± 6 (9–32) 19 ± 4 (11–27)
Distal descending aorta diameter (mm) 18 ± 5 (7–28) 16 ± 4 (8–24)
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Demographic parameters
Aortic diameters vary by BSA [91, 93] but do not show 
sex differences in children [92, 93]. Aortic area has not 
been shown to be dependent upon sex differences either 
[92].
Studies included in this review
Reference ranges for parameters measured in children 
are frequently presented in z-scores and reference curves 
using the LMS method as described under the LV/RV 
parameter section in children above.
There are three publications of systematic evaluation of 
aortic dimensions (diameter and/or area) in children that 
vary by CMR-technique, measurement technique and 
data presentation (Table 43).
In this review we present (a) LMS parameters to cal-
culate z-scores for aortic cross-section area based on 
reference [92] (Tables  44, 45) (b) regression equations 
of normal aortic diameters measured at 9 different sites 
based on [91] (Table  46) and (c) normal areas of the 
ascending aorta from [93] (Table 47).
Due to the differences in acquisition sequences, 
measurement techniques, and presentation of results, 
weighted mean values are not presented.
Normal aortic distensibilityand pulse wave 
velocity (PWV) in adults
CMR acquisition parameters
Pulse wave velocity (PWV) calculations using a veloc-
ity-encoded CMR with phase contrast sequences allow 
accurate assessment of aortic systolic flow wave and the 
blood flow velocity. The sequence should be acquired at 
the level of the bifurcation of the pulmonary trunk, per-
pendicular to both, the ascending and descending aorta. 
The distance between two aortic locations (aortic length) 
can be estimated from axial and coronal cine breath hold 
bSSFP sequences covering the whole aortic arch [94]. 
Alternatively, sagittal oblique views of the aortic arch can 
be acquired e.g. using a black blood spin echo sequence 
[88].
Another parameter of aortic stiffness is aortic distensi-
bility. The cross sectional aortic area at different phases 
of the cardiac cycle is measured using ECG-gated bSSFP 
cine imaging to assess aortic distensibility by CMR. Mod-
ulus images of cine phase contrast CMR can be used as 
well [95].
CMR analysis methods
PWV is the most validated method to quantify arterial 
stiffness using CMR. PWV is calculated by measuring 
the pulse transit time of the flow curves (Δt) and the dis-
tance (D) between the ascending and descending aortic 
locations of the phase contrast acquisition [88]: Aortic 
PWV = D/ Δt (Fig. 12).
PWV increases with stiffening of arteries since the 
stiffened artery conducts the pulse wave faster com-
pared to more distensible arteries.
Table 40 Absolute and  BSA indexed normal values 
of ascending aortic luminal diameter for men and women 
of  different age categories measured on  phase contrast 
images according to [83]
n number of study subjects, BSA body surface area










45–54 32 (27–37) 29 (25–34)
55–64 33 (28–41) 30 (26–36)
65–74 34 (29–41) 31 (26–36)
75–84 35 (29–41) 31 (27–37)
Values indexed to BSA (mm/m2)
45–54 16 (13–20) 17 (14–21)
55–64 17 (14–21) 18 (15–22)
65–74 18 (14–22) 18 (15–22)
75–84 19 (15–23) 20 (15–28)
Table 41 Normal values of  descending thoracic aortic 
diameter, area and  wall thickness for  young men 
and women (25–35 years) according to [84]
Measurements obtained on axial reformatted images of a fat suppressed 
3‑dimensional‑T1‑black blood VISTA (volume isotropic turbo spin echo 
acquisition) sequence. Calculated average vessel diameter and area as well as 
wall thickness and wall area of the descending aorta.
n number of study subjects








Luminal diameter descending 
aorta (mm)
19 (17–21) 17 (16–19)
Total diameter descending aorta 
(mm)
22 (20–24) 20 (19–22)
Luminal area descending aorta 
 (cm2)
2.9 (2.2–3.5) 2.3 (2.0–2.8)
Total area descending aorta  (cm2) 3.9 (3.1–4.6) 3.3 (2.8–3.9)
Wall area descending aorta  (cm2) 1.0 (0.8–1.2) 1.0 (0.8–1.1)
Wall thickness descending aorta 
(mm)
1.5 (1.4–1.8) 1.5 (1.4–1.9)
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Aortic distensibility is calculated with the fallowing 
formula after measuring the minimum and maximum 
aortic cross sectional area [96]:
Demographic parameters
Greater ascending aorta diameter and changes in aor-
tic arch geometry with greater age was associated with 
increased regional stiffness of the aorta, especially of the 
ascending portion. The relationship of age with measures 
of aortic stiffness is non-linear and the decrease of aortic 
distensibility occurs particularly before the fifth decade 
of life [88]. Males have stiffer aortas compared to females 
[97].
Aortic distensibility = (minimal area−maximal area)/(minimal area×�P× 1000)
where�P is the pulse pressure in mmHg.
Studies included in this review
Two studies with a total sample size of more than 40 sub-
jects reported reference ranges for PWV and/or disten-
sibility in healthy subjects (Table 48): Kim et al. present 
reference ranges for PWV and distensibility for a cohort 
of 124 healthy Asian subjects [98]. Since both parameters 
have been shown to be highly age dependent, reference 
ranges are given per age decile according to the original 
publication [98]. However, sample size per decile was 
small (between 21 and 28 subjects) and standard devia-
tions are relatively large (Tables 49, 50). In the study by 
Table 42 Normal diameters of  the  aortic root for  men and  women measured on  sagittal left ventricular outflow tract 
bSSFP
Measurements obtained as shown in Fig. 10.
n number of study subjects included in the weighted mean values, bSSFP balanced steady‑state free precession, meanp pooled weighted mean, SDp pooled standard 
deviation, LL lower limit, UL upper limit, BSA body surface area
a Pooled weighted values from references [11, 86]
b Values from reference [11]
c Pooled weighted values from references [11, 85, 86]
d Pooled weighted values from references [11, 85]
e Calculated as  meanp ± 2*SDp
Parameter Men Women
n Meanp SDp LL–UL
e n Meanp SDp LL–UL
e
Aortic annulus diameter (mm)a 299 23 5 14–33 328 20 3 14–27
Aortic annulus diameter/BSA (mm/m2)b 91 12 1 10–14 89 12 1 10–14
Aortic sinus diameter (mm)c 359 32 6 19–45 388 28 5 17–38
Aortic sinus diameter/BSA (ml/m2)d 151 17 2 13–21 149 17 2 13–21
Sinotubular junction diameter (mm)a 299 25 6 12–38 328 21 5 12–31
Sinotubular junction diameter/BSA (mm/m2)b 91 13 2 10–17 89 14 2 10–17
Table 43 References, normal aortic dimensions in children
n number of study subject
First author, year CMR technique n, male:female Age 
range 
(years)
Kaiser, 2008 [91] 1.5 T; contrast enhanced CMRA; shortest diameter measured on cross‑sectional reformatted images at 
9 locations
30:23 2–20
Kutty, 2012 [93] 1.5 T; magnitude image of a through‑plane free‑breathing phase contrast sequence; cross‑sectional 
area calculated based on measurement of the maximal external aortic diameter perpendicular to 
the vessel and perpendicular to the maximal diameter in systole 1 to 2 cm distal to the sinotubular 
junction
55:50 4–20
Voges, 2012 [92] 3 T; cross sectional cine gradient echo images acquired at 4 positions perpendicular to the aortic axis, 
measurements obtained at maximal distension of the aorta
30:41 2–28
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Eikendal et  al. reference values for PWV in young (25–
35 years) healthy subjects are given (Table 51) [84].
With respect to PWV, in this review we present refer-
ence ranges for the distance between the ascending and 
the proximal descending thoracic aorta. This range is 
frequently measured since measurements at both loca-
tions can be obtained simultaneously on a single 2D 
acquisition at the level of the bifurcation of the pulmo-
nary artery. PWV for other distances (ascending to dis-
tal descending aorta and total PWV) can be found in the 
original publications [84, 98]. In addition to the ascend-
ing and proximal descending thoracic aorta, distensibility 
for the distal descending and the total aorta is presented 
in the original publication by Kim et al. [98].
Table 44 LMS parameters to  calculate z-scores for  aortic cross-sectional area relative to  age for  boys according 
to reference [92]
Aortic area measured at maximum distension of the aorta on cross sectional cine gradient echo images acquired perpendicular to the aortic axis (n = 30)
LMS, L = Lambda (skewness of the distribution), M = Mu (median), S = Sigma (variance)
z‑score = [(X/M)L – 1] / (L*S), where X is the measured aortic area in  mm2 and L, M and S are the values interpolated for the child’s age; lower and upper limits 
correspond to a z‑score of ‑2 and 2
a Age in years
b Measured above the diaphragm
Agea Ascending aorta Aortic arch Aortic isthmus Descending  aortab
L M S L M S L M S L M S
 < 1 0.3091 91.5360 0.1207 0.8668 80.1737 0.1898 0.1267 53.0050 0.1987 1.5823 44.6080 0.1100
1 0.3091 120.6960 0.1274 0.8668 101.7001 0.1897 0.1267 68.7198 0.1974 1.5823 57.0317 0.1115
2 0.3091 149.8560 0.1341 0.8668 123.2265 0.1895 0.1267 84.4347 0.1960 1.5823 69.4554 0.1129
3 0.3091 179.0160 0.1408 0.8668 144.7529 0.1894 0.1267 100.1495 0.1946 1.5823 81.8791 0.1143
4 0.3091 208.1812 0.1475 0.8668 166.2791 0.1893 0.1267 115.8653 0.1932 1.5823 94.3035 0.1158
5 0.3091 238.3791 0.1542 0.8668 187.7555 0.1891 0.1267 131.7743 0.1918 1.5823 106.8833 0.1172
6 0.3091 272.8715 0.1604 0.8668 208.8732 0.1890 0.1267 148.2790 0.1904 1.5823 119.9057 0.1186
7 0.3091 311.2493 0.1660 0.8668 229.2411 0.1888 0.1267 164.9648 0.1891 1.5823 133.0488 0.1201
8 0.3091 346.8686 0.1707 0.8668 248.8676 0.1887 0.1267 180.7624 0.1877 1.5823 145.5984 0.1215
9 0.3091 380.0230 0.1748 0.8668 268.0557 0.1886 0.1267 195.7825 0.1863 1.5823 157.5124 0.1229
10 0.3091 413.8181 0.1782 0.8668 287.2956 0.1884 0.1267 210.6578 0.1849 1.5823 169.3366 0.1244
11 0.3091 446.7220 0.1812 0.8668 306.7317 0.1883 0.1267 225.5414 0.1835 1.5823 181.3951 0.1258
12 0.3091 476.5703 0.1841 0.8668 326.2205 0.1881 0.1267 240.3324 0.1822 1.5823 193.8192 0.1272
13 0.3091 501.7973 0.1870 0.8668 345.4511 0.1880 0.1267 254.6975 0.1808 1.5823 206.4812 0.1287
14 0.3091 524.0769 0.1902 0.8668 364.2701 0.1879 0.1267 268.8289 0.1794 1.5823 219.2939 0.1301
15 0.3091 546.3695 0.1937 0.8668 382.7610 0.1877 0.1267 282.9653 0.1780 1.5823 232.0152 0.1316
16 0.3091 569.8955 0.1972 0.8668 400.9805 0.1876 0.1267 296.9424 0.1766 1.5823 244.3629 0.1330
17 0.3091 594.7536 0.2003 0.8668 418.9724 0.1875 0.1267 310.5833 0.1752 1.5823 256.2294 0.1344
18 0.3091 620.9611 0.2025 0.8668 436.7805 0.1873 0.1267 323.7094 0.1739 1.5823 267.5155 0.1359
19 0.3091 647.1204 0.2034 0.8668 454.4484 0.1872 0.1267 336.0814 0.1725 1.5823 278.0681 0.1373
20 0.3091 670.2706 0.2030 0.8668 472.0177 0.1871 0.1267 347.4348 0.1711 1.5823 287.6962 0.1387
21 0.3091 690.0681 0.2014 0.8668 489.5219 0.1869 0.1267 357.7775 0.1697 1.5823 296.3958 0.1402
22 0.3091 706.8583 0.1990 0.8668 506.9924 0.1868 0.1267 367.1860 0.1683 1.5823 304.2102 0.1416
23 0.3091 720.9831 0.1960 0.8668 524.4603 0.1866 0.1267 375.7366 0.1670 1.5823 311.1823 0.1430
24 0.3091 732.2902 0.1926 0.8668 541.9124 0.1865 0.1267 383.4824 0.1656 1.5823 317.3075 0.1445
25 0.3091 740.4053 0.1889 0.8668 559.3076 0.1864 0.1267 390.6086 0.1642 1.5823 322.5658 0.1459
26 0.3091 747.1815 0.1849 0.8668 576.7470 0.1862 0.1267 397.7409 0.1628 1.5823 327.1568 0.1473
27 0.3091 754.8518 0.1805 0.8668 594.3196 0.1861 0.1267 405.3735 0.1614 1.5823 331.4000 0.1488
28 0.3091 763.4054 0.1758 0.8668 611.9863 0.1860 0.1267 413.3799 0.1601 1.5823 335.4719 0.1502
29 0.3091 772.1960 0.1711 0.8668 629.6783 0.1858 0.1267 421.4867 0.1587 1.5823 339.4979 0.1516
30 0.3091 780.9891 0.1663 0.8668 647.3706 0.1857 0.1267 429.5945 0.1573 1.5823 343.5234 0.1531
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Normal aortic distensibility and pulse wave 
velocity (PWV) in children
CMR acquisition parameters
In the only publication of aortic distensibility and PWV 
by CMR in children, distensibility was obtained on gradi-
ent echo cine images and pulse wave velocity was meas-
ured on phase-contrast cine CMR [92].
CMR analysis methods
Distensibility was calculated as  (Amax –  Amin)/Amin x  (Pmax 
–  Pmin), where  Amax and  Amin represent the maximal and 
minimal cross-sectional area of the aorta, and  Pmax and 
 Pmin represent the systolic and diastolic blood pressure 
measured with a sphygmomanometer cuff around the 
right arm.
Table 45 LMS parameters to  calculate z-scores for  aortic cross-sectional area relative to  age for  girls according 
to reference [92]
Aortic area measured at maximum distension of the aorta on cross sectional cine gradient echo images acquired perpendicular to the aortic axis (n = 41)
LMS, L = Lambda (skewness of the distribution), M = Mu (median), S = Sigma (variance)
z‑score = [(X/M)L – 1] / (L*S), where X is the measured aortic area in  mm2 and L, M and S are the values interpolated for the child’s age; lower and upper limits 
correspond to a z‑score of ‑2 and 2
a Age in years
b Measured above the diaphragm
Agea Ascending aorta Aortic arch Aortic isthmus Descending  aortab
L M S L M S L M S L M S
 < 1  − 0.7876 121.1903 0.2152 2.1750 73.6299 0.2114 0.1033 60.0696 0.1621 0.9371 41.0795 0.1398
1  − 0.7876 145.9923 0.2140 2.1750 92.7307 0.2089 0.1033 72.6142 0.1617 0.9371 52.4930 0.1398
2  − 0.7876 170.7944 0.2127 2.1750 111.8315 0.2064 0.1033 85.1587 0.1613 0.9371 63.9065 0.1398
3  − 0.7876 195.5999 0.2114 2.1750 130.9296 0.2039 0.1033 97.7032 0.1609 0.9371 75.3185 0.1398
4  − 0.7876 220.4539 0.2102 2.1750 149.9904 0.2013 0.1033 110.2465 0.1605 0.9371 86.7100 0.1398
5  − 0.7876 245.4281 0.2089 2.1750 168.9588 0.1988 0.1033 122.7870 0.1601 0.9371 98.0510 0.1398
6  − 0.7876 270.5738 0.2076 2.1750 187.8089 0.1963 0.1033 135.3263 0.1597 0.9371 109.3784 0.1398
7  − 0.7876 295.9027 0.2064 2.1750 206.5696 0.1938 0.1033 147.8724 0.1593 0.9371 120.8531 0.1398
8  − 0.7876 321.3290 0.2051 2.1750 225.2367 0.1913 0.1033 160.3915 0.1588 0.9371 132.5201 0.1398
9  − 0.7876 346.5367 0.2038 2.1750 243.7024 0.1887 0.1033 172.7395 0.1584 0.9371 144.0843 0.1398
10  − 0.7876 371.3379 0.2026 2.1750 261.8643 0.1862 0.1033 184.8049 0.1580 0.9371 155.3776 0.1398
11  − 0.7876 395.6874 0.2013 2.1750 279.6207 0.1837 0.1033 196.5286 0.1576 0.9371 166.4608 0.1398
12  − 0.7876 419.5583 0.2000 2.1750 296.8402 0.1812 0.1033 207.8452 0.1572 0.9371 177.3057 0.1398
13  − 0.7876 442.8024 0.1988 2.1750 313.4236 0.1787 0.1033 218.7232 0.1568 0.9371 187.8984 0.1398
14  − 0.7876 465.1326 0.1975 2.1750 329.2852 0.1761 0.1033 229.1136 0.1564 0.9371 198.1163 0.1398
15  − 0.7876 486.2071 0.1962 2.1750 344.3674 0.1736 0.1033 238.9630 0.1560 0.9371 207.7776 0.1398
16  − 0.7876 505.7398 0.1950 2.1750 358.6387 0.1711 0.1033 248.2461 0.1556 0.9371 216.7982 0.1398
17  − 0.7876 523.5836 0.1937 2.1750 372.0983 0.1686 0.1033 256.9723 0.1552 0.9371 225.1710 0.1398
18  − 0.7876 539.7165 0.1924 2.1750 384.7434 0.1661 0.1033 265.1479 0.1547 0.9371 232.7857 0.1398
19  − 0.7876 554.1764 0.1912 2.1750 396.5833 0.1635 0.1033 272.7929 0.1543 0.9371 239.5830 0.1398
20  − 0.7876 567.1207 0.1899 2.1750 407.6567 0.1610 0.1033 279.9469 0.1539 0.9371 245.6109 0.1398
21  − 0.7876 578.7817 0.1886 2.1750 418.0442 0.1585 0.1033 286.6730 0.1535 0.9371 251.0496 0.1398
22  − 0.7876 589.4770 0.1873 2.1750 427.8971 0.1560 0.1033 293.0630 0.1531 0.9371 256.1671 0.1398
23  − 0.7876 599.5300 0.1861 2.1750 437.3887 0.1534 0.1033 299.2101 0.1527 0.9371 261.1406 0.1398
24  − 0.7876 609.3164 0.1848 2.1750 446.7229 0.1509 0.1033 305.2232 0.1523 0.9371 266.1367 0.1398
25  − 0.7876 619.1593 0.1835 2.1750 456.0570 0.1484 0.1033 311.2003 0.1518 0.9371 271.2515 0.1398
26  − 0.7876 629.1747 0.1822 2.1750 465.4360 0.1459 0.1033 317.2057 0.1514 0.9371 276.5640 0.1398
27  − 0.7876 639.3019 0.1810 2.1750 474.8382 0.1433 0.1033 323.2314 0.1510 0.9371 281.9813 0.1398
28  − 0.7876 649.4860 0.1797 2.1750 484.2530 0.1408 0.1033 329.2650 0.1506 0.9371 287.4341 0.1398
29  − 0.7876 659.6776 0.1784 2.1750 493.6694 0.1383 0.1033 335.2995 0.1502 0.9371 292.8916 0.1398
30  − 0.7876 669.8691 0.1772 2.1750 503.0858 0.1358 0.1033 341.3341 0.1498 0.9371 298.3491 0.1398
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PWV was calculated as Δx/Δt, where Δx is defined 
as the length of the centerline between the sites of flow 
measurement in the ascending and descending aorta 
and Δt represents the time delay between the flow 
curve obtained in the descending aorta relative to the 
flow curve obtained in the ascending aorta (Fig. 12).
Demographic parameters
Aortic distensibility and PWV did not vary by gender. 
Aortic distensibility decreases with age and correlates 
with height, body weight and BSA. PWV has been shown 
to increase with age [92].
Studies included in this review
There is a single publication only of a systematic evalua-
tion of normal aortic distensibility and PWV in children 
(Table 52). In this review we present LMS parameters to 
calculate z-scores for distensibility of the ascending aorta 
and PWV based on reference [92] (Tables 53, 54). In the 
original publication LMS parameters for distensibility 
at 3 other levels of the thoracic aorta (aortic arch, aor-
tic isthmus and distal descending aorta) are presented in 
addition [92].
Normal dimensions and distension 
of the pulmonary arteries in adults
CMR acquisition parameters
In the study by Burman et  al. listed in this review [99] 
dimensions of the pulmonary arteries were measured on 
bSSFP images (Table  55). Burman et  al. acquired cross 
sectional images of the main and the right and left pul-
monary artery based on an oblique sagittal image of the 
Table 46 Normal aortic diameters in  children measured 
on  a  contrast enhanced 3D-CMRA according to  reference 
[91]
Shortest diameter measured on cross‑sectional reformatted images (n = 53). 
Sites of measurement are shown in Fig. 9
z‑score = (measured diameter − predicted diameter)/SD of residuals; lower and 
upper limits correspond to a z‑score of ‑2 and 2
BSA body surface area, SD standard deviation
Site Predicted diameter (mm) SD 
of residuals 
(mm)
Aortic sinus 0.57 + 19.37*BSA0.5 2.38
Sinotubular junction  − 0.03 + 16.91*BSA0.5 1.92
Ascending aorta  − 1.33 + 18.6*BSA0.5 1.99
Proximal to the origin of the 
brachiocephalic artery
 − 3.38 + 20.07*BSA0.5 1.69
First transverse segment  − 3.52 + 18.66*BSA0.5 1.63
Second transverse segment  − 2.63 + 16.5*BSA0.5 1.31
Isthmic región  − 3.37 + 16.52*BSA0.5 1.46
Descending aorta  − 1.12 + 14.42*BSA0.5 1.64
Thoracoabdominal aorta at 
the level of the diaphragm
1.27 + 9.89*BSA0.5 1.34
Table 47 Normal aortic area on  phase contrast cine 
images according to reference [93]
Cross sectional area calculated based on measurement of the maximal external 
aortic diameter perpendicular to the vessel and perpendicular to the maximal 
diameter in systole 1 to 2 cm distal to the sinotubular junction on the magnitude 
image of a phase contrast cine sequence (n = 105)
BSA body surface area
Site Predicted area  (cm2)
Ascending aorta  − 0.0386 + 2.913*BSA
Fig. 12 Measurement of pulse wave velocity according to 
reference [92]. Δx: length of the centerline between the sites of flow 
measurement in the ascending and descending aorta; Δt: time delay 
between the flow curves obtained in the descending aorta relative to 
the flow curve obtained in the ascending aorta calculated between 
the midpoint of the systolic up slope tails on the flow versus time 
curves of the ascending aorta (ta1) and the descending aorta (ta2)
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RV outflow tract and pulmonary trunk, respectively (for 
the main pulmonary artery) and an axial image acquired 
at the level of the bifurcation of the main pulmonary 
artery (for the left and right pulmonary artery) (Fig. 13). 
With three-dimensional acquisition, reconstruction of 
the imaging plane can be performed after image acquisi-
tion using multiplanar reformation.
Other sequences could also be used to obtain dimen-
sions of the pulmonary arteries such as a three-dimen-
sional contrast enhanced CMRA with contrast timing 
optimized to enhance the pulmonary arteries. Non-con-
trast techniques include respiratory and ECG-gated 3D 
bSSFP sequence and cine phase contrast imaging. How-
ever, similar to the aorta, measurements of the pulmo-
nary artery are expected to vary by the sequence type 
and might not be comparable [82]. In contrast to static 
sequences, acquisition of dynamic sequences, e.g. cine 
bSSFP, enable measurements at systole and diastole and 
calculation of distension.
CMR analysis methods
Luminal areas and diameters of the pulmonary arteries 
were measured on cross sectional images of the respec-
tive vessel at minimal diastolic and minimal systolic 
expansion. Since the cross section of the vessel is usually 
not perfectly circular, data presented in Table  56 shows 
the mean diameter of two diameters that were acquired 
per vessel and phase calculated from the greatest diam-
eter and the lesser diameter orthogonal to the greater 
diameter. Percent systolic distension was calculated as 
[(maximum area – minimum area) * 100/minimum area].
Demographic parameters
Area and mean diameters of the pulmonary arteries are 
greater in men compared to women and greater in sys-
tole compared to diastole. Some measurements of the 
area and the mean diameter of the pulmonary arter-
ies slightly increase with BSA and age, while systolic 
Table 48 References, normal aortic pulse wave velocity (PWV) and distensibility
n number of study subjects, bSSFP balanced steady‑state free precession, PWV pulse wave velocity
First author, year CMR technique n, male:female Age range (years)
Kim, 2013 [98] 1.5 T, phase contrast CMR to calculate PWV for 3 distances of the aorta; transit time cal‑
culated from the midpoint of the systolic up‑slope on the flow versus time curve; cross 
sectional cine bSSFP at 4 levels of the aorta to calculate distensibility
61:63 20–79
Eikendal, 2016 [84] 3 T, phase contrast CMR to calculate PWV for 2 distances of the aorta, time delay calculated 
from velocity–time curves
57:61 25–35
Table 49 Normal values of  regional aortic distensibility 
for men and women according to [98]
n number of study subjects
a Measurements obtained at the level of the bifurcation of the pulmonary artery
Level Age (years) Men (n = 61)





Mean ± SD 
 (10–3 mm/
Hg)
Ascending  aortaa 20–29 5.6 ± 1.5 7.9 ± 3.4
30–39 3.6 ± 1.4 6.5 ± 3.0
40–49 3.5 ± 1.5 5.3 ± 1.2
50–59 3.2 ± 1.6 3.6 ± 1.1
60–69 2.1 ± 1.3 2.7 ± 1.0
Proximal descending  aortaa 20–29 4.2 ± 0.9 6.0 ± 1.4
30–39 3.8 ± 1.3 5.5 ± 1.9
40–49 3.3 ± 0.6 4.2 ± 1.2
50–59 2.9 ± 1.1 3.7 ± 1.3
60–69 2.3 ± 0.9 3.1 ± 0.9
Table 50 Normal values for  aortic pulse wave velocity 
according to [98]
Regional pulse wave velocity from the ascending to the upper descending 
thoracic aorta
n number of study subjects
Age (years) n Median 
(5th–95th 
percentile) (m/s)
20–29 26 3.7 (3.4–4.0)
30–39 28 3.8 (3.5–6.0)
40–49 24 4.3 (3.7–5.0)
50–59 25 5.6 (5.4–7.2)
60–69 21 9.0 (7.4–12.4)
Table 51 Normal values for  aortic pulse wave velocity 
in young men and women (25–35 years) according to [84]
Regional pulse wave velocity from the ascending to the upper descending 
thoracic aorta
n number of study subjects
Men (n = 57)
Median (10th–90th percentile) 
(m/s)
Women (n = 61)
Median (10th–90th percentile) 
(m/s)
4.6 (3.9–5.6) 4.5 (3.6–6.0)
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Table 52 References, normal distensibility and pulse wave velocity (PWV) in children
n number of study subjects, GRE gradient echo, PWV pulse wave velocity
First author, year CMR technique n, male:female Age range (years)
Voges, 2012 [92] 3 T; cross sectional cine GRE at 4 levels of the thoracic aorta to calculate distensibility; phase 
contrast CMR to calculate PWV for the distance between the sinotubular junction and the 
proximal descending aorta, transit time calculated from the midpoint of the systolic up‑
slope on the flow versus time curve
30:41 2–28
Table 53 LMS parameters to  calculate z-scores for  distensibility of  the  ascending aorta relative to  age in  children 
according to reference [92]
Distensibility was calculated based on measurements of the aortic area at systole and diastole on cross sectional cine gradient echo images obtained perpendicular to 
the axis of the ascending thoracic aorta.
LMS, L = Lambda (skewness of the distribution), M = Mu (median), S = Sigma (variance).
z‑score = [(X/M)L – 1] / (L*S), where X is the measured aortic distensibility in  10–3 mm  Hg−1 and L, M and S are the values interpolated for the child’s age; lower and 
upper limits correspond to a z‑score of ‑2 and 2.
n number of study subjects.
Age (years) Male (n = 30) Female (n = 41)
L M S L M S
 < 1  − 0.1879 12.3602 0.3680  − 0.0721 12.7303 0.2388
1  − 0.1879 11.9220 0.3680  − 0.0721 12.5028 0.2396
2  − 0.1879 11.4838 0.3680  − 0.0721 12.2753 0.2403
3  − 0.1879 11.0456 0.3680  − 0.0721 12.0477 0.2411
4  − 0.1879 10.6075 0.3680  − 0.0721 11.8176 0.2419
5  − 0.1879 10.1700 0.3680  − 0.0721 11.5817 0.2427
6  − 0.1879 9.7343 0.3680  − 0.0721 11.3421 0.2435
7  − 0.1879 9.2990 0.3680  − 0.0721 11.1121 0.2443
8  − 0.1879 8.8602 0.3680  − 0.0721 10.9051 0.2451
9  − 0.1879 8.4151 0.3680  − 0.0721 10.7290 0.2459
10  − 0.1879 7.9776 0.3680  − 0.0721 10.5679 0.2467
11  − 0.1879 7.5683 0.3680  − 0.0721 10.3851 0.2474
12  − 0.1879 7.2051 0.3680  − 0.0721 10.1582 0.2482
13  − 0.1879 6.9030 0.3680  − 0.0721 9.8884 0.2490
14  − 0.1879 6.6697 0.3680  − 0.0721 9.5911 0.2498
15  − 0.1879 6.5089 0.3680  − 0.0721 9.2905 0.2506
16  − 0.1879 6.4138 0.3680  − 0.0721 9.0033 0.2514
17  − 0.1879 6.3729 0.3680  − 0.0721 8.7345 0.2522
18  − 0.1879 6.3745 0.3680  − 0.0721 8.4850 0.2529
19  − 0.1879 6.4062 0.3680  − 0.0721 8.2574 0.2537
20  − 0.1879 6.4551 0.3680  − 0.0721 8.0546 0.2545
21  − 0.1879 6.5111 0.3680  − 0.0721 7.8749 0.2553
22  − 0.1879 6.5646 0.3680  − 0.0721 7.7106 0.2561
23  − 0.1879 6.6062 0.3680  − 0.0721 7.5479 0.2569
24  − 0.1879 6.6277 0.3680  − 0.0721 7.3842 0.2577
25  − 0.1879 6.6242 0.3680  − 0.0721 7.2113 0.2584
26  − 0.1879 6.5975 0.3680  − 0.0721 7.0343 0.2592
27  − 0.1879 6.5577 0.3680  − 0.0721 6.8647 0.2600
28  − 0.1879 6.5116 0.3680  − 0.0721 6.6951 0.2608
29  − 0.1879 6.4643 0.3680  − 0.0721 6.5250 0.2616
30  − 0.1879 6.4170 0.3680  − 0.0721 6.3550 0.2624
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Table 54 LMS parameters to  calculate z-scores for  pulse wave velocity (PWV) relative to  age in  children according 
to reference [92]
Pulse wave velocity calculated by phase contrast CMR for the distance between the sinotubular junction and the proximal descending aorta. Transit time calculated 
from the midpoint of the systolic up‑slope on the flow versus time curve (Fig. 12).
LMS, L = Lambda (skewness of the distribution), M = Mu (median), S = Sigma (variance)
z‑score = [(X/M)L – 1] / (L*S), where X is the measured pulse wave velocity in m/s and L, M and S are the values interpolated for the child’s age; lower and upper limits 
correspond to a z‑score of ‑2 and 2.
n number of study subjects
Age (years) Male (n = 30) Female (n = 41)
L M S L M S
 < 1 1.4844 3.4147 0.2122  − 1.5196 2.7808 0.1468
1 1.4844 3.4367 0.2122  − 1.5196 2.8144 0.1469
2 1.4844 3.4587 0.2122  − 1.5196 2.8481 0.1469
3 1.4844 3.4808 0.2122  − 1.5196 2.8817 0.1469
4 1.4844 3.5028 0.2122  − 1.5196 2.9154 0.1470
5 1.4844 3.5248 0.2122  − 1.5196 2.9490 0.1470
6 1.4844 3.5469 0.2122  − 1.5196 2.9827 0.1470
7 1.4844 3.5689 0.2122  − 1.5196 3.0163 0.1470
8 1.4844 3.5909 0.2122  − 1.5196 3.0499 0.1471
9 1.4844 3.6129 0.2122  − 1.5196 3.0836 0.1471
10 1.4844 3.6350 0.2122  − 1.5196 3.1172 0.1471
11 1.4844 3.6570 0.2122  − 1.5196 3.1509 0.1471
12 1.4844 3.6790 0.2122  − 1.5196 3.1845 0.1472
13 1.4844 3.7011 0.2122  − 1.5196 3.2182 0.1472
14 1.4844 3.7231 0.2122  − 1.5196 3.2518 0.1472
15 1.4844 3.7451 0.2122  − 1.5196 3.2855 0.1473
16 1.4844 3.7672 0.2122  − 1.5196 3.3192 0.1473
17 1.4844 3.7892 0.2122  − 1.5196 3.3528 0.1473
18 1.4844 3.8112 0.2122  − 1.5196 3.3865 0.1473
19 1.4844 3.8333 0.2122  − 1.5196 3.4201 0.1474
20 1.4844 3.8553 0.2122  − 1.5196 3.4538 0.1474
21 1.4844 3.8773 0.2122  − 1.5196 3.4875 0.1474
22 1.4844 3.8994 0.2122  − 1.5196 3.5211 0.1475
23 1.4844 3.9214 0.2122  − 1.5196 3.5548 0.1475
24 1.4844 3.9434 0.2122  − 1.5196 3.5885 0.1475
25 1.4844 3.9655 0.2122  − 1.5196 3.6221 0.1476
26 1.4844 3.9875 0.2122  − 1.5196 3.6558 0.1476
27 1.4844 4.0096 0.2122  − 1.5196 3.6895 0.1476
28 1.4844 4.0316 0.2122  − 1.5196 3.7231 0.1476
29 1.4844 4.0536 0.2122  − 1.5196 3.7568 0.1477
30 1.4844 4.0757 0.2122  − 1.5196 3.7905 0.1477
Table 55 Reference, normal dimensions and distension of the pulmonary arteries in adults
n number of study subjects, bSSFP balanced steady‑state free precession
First author, year CMR technique n, male:female Age range (years)
Burman, 2016 [99] 1.5 T, cross sectional bSSFP, luminal area and mean diameters 60:60 20–79
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distension decrease with age. For a detailed description 
of the relationship of the area, mean diameters and sys-
tolic distension of the pulmonary arteries with age and 
BSA please see [99].
Studies included in this review
One publication of reference ranges of the area, diam-
eters and distension of the pulmonary arteries in adults 
was found using a current CMR technique, sufficient 
sample size (> 40 subjects per gender) and a clear descrip-
tion of image acquisition and measurements [99]. In the 
original publication, reference ranges were presented for 
age deciles for subjects between 20 and 79 years with 10 
subjects per decile and gender. However, since the differ-
ences between age deciles were small and might not be 
clinically relevant and for sample size considerations, in 
the current review only values of the entire cohort sepa-
rated by gender are presented.
Fig. 13 Measurement of the dimensions of the pulmonary arteries on bSSFP images according to [99]. Oblique sagittal image of the main 
pulmonary artery (a). The pale band in a shows the acquisition plane of the cross sectional image of the main pulmonary artery in b. Right and left 
pulmonary arteries on the scout image (c) with band indicating the location of cine acquisitions transecting the right (d) and left (e) pulmonary 
artery
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Normal dimensions of the pulmonary arteries 
in children
CMR acquisition parameters
In analogy to dimensions of the pulmonary arteries 
in adults, different sequences might be used to obtain 
measurements. In the studies listed below, a contrast 
enhanced three-dimensional CMRA and a cross sec-
tional through-plane free-breathing phase contrast 
sequence were acquired to obtain the measurements 
[93, 100].
CMR analysis methods
Knobel et  al. obtained measurements of the pulmonary 
arteries on reconstructed maximum intensity projection 
(MIP) images (slice thickness is not mentioned) perpen-
dicular to the respective vessel (Fig. 14) [100]. The diam-
eter of the main pulmonary artery was obtained on an 
axial and a reformatted sagittal oblique view, the diam-
eters of the proximal and distal right and left pulmonary 
artery were measured on an axial and reformatted right 
and left anterior oblique (coronal oblique) views.
In the study by Kutty et al. the maximal external diam-
eter of the main pulmonary artery (d1) was measured on 
the cross sectional magnitude image of the PC sequence 
in systole and also the diameter (d2) perpendicular to d1 
[93]. After derivation of the radii (r1 and r2), the area was 
calculated as πr1r2.
Demographic parameters
In both studies a relationship between pulmonary artery 
diameter and BSA was described [93, 100]. Kutty et  al. 
could not find a significant gender difference of the size 
of the main pulmonary artery.
Studies included in this review
Two studies were identified presenting normal values 
of the size of the pulmonary arteries in children [93, 
100] (Table 57). Knobel et al. included 69 children rang-
ing from 2 to 20 years with a previous history of malig-
nancy that were assessed for potential port-a-cath related 
complications but normal cardiovascular anatomy and 
no evidence of cardiovascular disease [100] (Table  58). 
In the study by Kutty et al. 105 normal healthy subjects 
between 4 and 20  years were included (data presented 
here; Table 59) and also subjects with repaired tetralogy 
of Fallot (not presented in this review) [93].
Due to the differences in sequence type, measurement 
technique and data presentation the normal values of the 
two studies are presented separately.
Normal values of myocardial T1 relaxation time 
and the extracellular volume (ECV)
CMR acquisition parameters
The field of myocardial T1 mapping has matured sig-
nificantly with several studies reporting T1 relaxation 
Table 56 Normal dimensions and distension of the pulmonary arteries in adults according to [99]
n number of study subjects, SD standard deviation, LL lower limit, UL upper limit, MPA main pulmonary artery, RPA right pulmonary artery, LPA left pulmonary artery
a Calculated as mean ± 2*SD
Vessel Parameter Men (n = 60) Women (n = 60)
Mean SD LL–ULa Mean SD LL–ULa
MPA Systolic diameter (mm) 27.4 2.6 21–33 25.3 2.6 19–31
Diastolic diameter (mm) 22.9 2.4 19–27 21.2 2.1 17–25
Systolic area  (cm2) 5.9 1.1 3.7–8.1 5.0 1.0 3.0–7.0
Diastolic area  (cm2) 4.2 0.8 2.6–5.8 3.6 0.7 2.2–5.0
Distension (%) 42.7 17.2 9–77 41.8 15.7 10–74
RPA Systolic diameter (mm) 20.2 2.9 14–26 17.8 2.4 14–22
Diastolic diameter (mm) 16.6 2.8 11–23 14.7 2.2 11–19
Systolic area  (cm2) 3.3 1.0 1.3–5.3 2.6 0.7 1.2–4.0
Diastolic area  (cm2) 2.2 0.8 0.6–3.8 1.8 0.6 0.6–3.0
Distension (%) 50.6 16.9 17–85 48.2 14.5 18–78
LPA Systolic diameter (mm) 20.1 2.4 16–24 18.4 2.1 14–22
Diastolic diameter (mm) 17.3 2.5 11–23 15.9 2.0 12–20
Systolic area  (cm2) 3.3 0.8 1.7–4.9 2.8 0.6 1.6–4.0
Diastolic area  (cm2) 2.4 0.7 1.0–3.8 2.1 0.5 1.1–3.1
Distension (%) 35.6 10.1 16–56 35.2 10.3 15–55
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times for normal cohorts [101]. An Expert Consensus 
document on parametric mapping has been published 
providing recommendations for the practical clinical 
application of T1, T2, T2*, and ECV mapping [102]. Most 
of the published myocardial T1 values have been 
acquired using variants of the Modified Look-Locker 
Fig. 14 Measurement of the diameters of the pulmonary arteries according to reference [100]. Diameters were measured perpendicular to the 
vessel on maximum intensity projection images. The diameters of the main pulmonary artery were obtained on an axial (a) and sagittal oblique 
(b) view and the diameters of the proximal and distal right and left pulmonary artery were obtained on axial (a) and right and left anterior oblique 
(paracoronal) views (c, d), respectively
Table 57 References, normal dimensions of the pulmonary arteries in children
n number of study subjects
First author, year CMR technique n, male:female Age 
range 
(years)
Knobel, 2011 [100] 1.5 T, contrast enhanced CMRA, diameters measured on images perpendicular to the vessel 41:28 2–20
Kutty, 2012 [93] 1.5 T; magnitude image of a through‑plane free‑breathing phase contrast sequence; cross sectional 
area calculated based on measurements of the maximal external aortic diameter perpendicular to 
the vessel and perpendicular to the maximal diameter obtained midway between the level of the 
pulmonary valve and the bifurcation of the branch pulmonary arteries
55:50 4–20
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Inversion Recovery (MOLLI) technique [103] includ-
ing the shortened-MOLLI (ShMOLLI) [104] method. 
Saturation recovery based techniques such as saturation 
recovery single-shot acquisition (SASHA) are alternative 
techniques but have less clinical evidence to date [105]. 
Images are typically acquired in diastole to limit cardiac 
motion and respiratory motion correction.
Native T1 maps are acquired without a contrast agent. 
Post contrast T1 maps allow assessment of gadolinium 
contrast distribution, as these agents shorten the T1 relaxa-
tion time of water. T1 maps acquired 10–30 min following 
injection of an extra-cellular non-protein binding gado-
linium contrast agent can be used to quantify the extracel-
lular volume fraction (ECV) [102]. Post contrast T1 values 
have been performed following a bolus or primed infusion 
(Equilibrium-EQCMR) with good agreement of ECV val-
ues up to 40% [106]. While the hematocrit can be approxi-
mated from the T1 of the blood in the LV cavity (“synthetic 
T1”), assessment of hematocrit by blood sampling as close 
as possible in time to the CMR (less than 24 h) is preferred 
due to normal daily variation of hematocrit [102].
Factors affecting T1 relaxation time and ECV
There are a number of CMR acquisition factors that 
can affect the measurement of normal T1 and ECV val-
ues. Field strength has a significant effect on T1 values; 
with 3 T scans producing 28% higher native T1 and 14% 
higher post contrast T1 values when compared with 
1.5 T [107]. Post contrast T1 is also affected by the dose 
and relaxivity of the contrast agent used, contrast clear-
ance, and the time between injection and measurement 
[107–109]. There is also greater heterogeneity for a T1 
native normal range at 3  T [107, 110, 111]. Further, it 
has been shown that T1 varies by cardiac phase (diastole 
versus systole) and region of measurement (septal versus 
non-septal) [107]. ECV values are relatively unaffected by 
field strength (3 T versus 1.5 T). Both native T1 and ECV 
values have been shown to be less reliable in the infero-
lateral wall likely secondary to off-resonance effects [107, 
112].
A number of pulse sequence parameters can affect nor-
mal values. For MOLLI pulse sequences the number of 
inversions, number of images following each inversion, 
and number of recovery beats between inversion pulses, 
and the flip angle affect normal values [101]. Further-
more, the type of inversion pulses, which may be vendor 
specific can also affect T1 values.
The aforementioned factors contribute to the large het-
erogeneity of published reference ranges. Heterogeneity 
in published values are present even if the same manufac-
turer scanner was used at the same field strength with the 
same pulse sequence [101]. It is thus imperative to stand-
ardize local pulse sequences and sequence parameters, 
Table 58 Normal diameters of  the  pulmonary arteries in  children measured on  a  contrast enhanced CMRA according 
to reference [100]
Diameters measured perpendicular to the vessel (Fig. 14).
Fitting model for regression: diameter = a + b*BSA0.5
z‑score = (measured diameter – predicted diameter)/SD of residuals; lower and upper limits correspond to a z‑score of ‑2 and 2.
BSA body surface area, SD standard deviation, RAO right anterior oblique view (paracoronal, parallel to right pulmonary artery; Fig. 14), LAO left anterior oblique view 
(paracoronal, parallel to left pulmonary artery; Fig. 14).
Site Predicted diameter (mm) SD 
of residuals 
(mm)
Main pulmonary artery (axial) 4.85 + 13.43*BSA0.5 2.72
Main pulmonary artery (sagittal) 1.04 + 17.07*  BSA0.5 2.01
Proximal right pulmonary artery (axial) 2.63 + 9.19*  BSA0.5 1.65
Distal right pulmonary artery (axial) 3.9 + 6.25*  BSA0.5 1.49
Proximal right pulmonary artery (RAO)  − 0.69 + 14.3*  BSA0.5 1.76
Distal right pulmonary artery (RAO)  − 1.08 + 14.62*  BSA0.5 1.6
Proximal left pulmonary artery (axial) 1.7 + 11.27*  BSA0.5 1.37
Distal left pulmonary artery (axial)  − 0.1 + 11.89*  BSA0.5 1.51
Proximal left pulmonary artery (LAO)  − 2.13 + 16.82*  BSA0.5 1.88
Distal left pulmonary artery (LAO)  − 2.08 + 13.64*  BSA0.5 1.5
Table 59 Normal pulmonary artery area measured 
on phase contrast cine images according to reference [93]
Cross sectional area calculated based on measurements of the maximal external 
aortic diameter perpendicular to the vessel and perpendicular to the maximal 
diameter obtained midway between the level of the pulmonary valve and the 
bifurcation of the branch pulmonary arteries.
BSA body surface area
Site Predicted area  (cm2)
Ascending aorta  − 0.2880 + 3.386*BSA
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and to follow current consensus guidelines for establish-
ing site specific reference ranges [102]. In contrast to 
other CMR parameters, the SCMR has indicated that lit-
erature normal values of T1 relaxation times should not 
serve as absolute reference values, but rather than site-
specific reference ranges should be established [102].
CMR analysis methods
T1 maps are based on pixel-wise quantification of longi-
tudinal relaxation from the T1-weighted source images. 
The native T1 relaxation time, expressed in milliseconds 
(ms), is a composite measurement reflecting the signal 
from water within multiple compartments within the 
myocardium including myocytes, the blood pool, and the 
interstitial space [113]. Under assumptions of an equilib-
rium of gadolinium concentrations between the blood 
pool and interstitium, pre and post contrast blood and 
myocardial T1 values can be used to quantify the parti-
tion coefficient of gadolinium which when multiplied by 
(1-hematocrit) quantifies the fractional volume of the 
extracellular space. This ECV is expressed as a percent-
age [114].
Offline post-processing involves manually tracing 
endocardial and epicardial contours [109, 115] (Fig.  15) 
or placing a region of interest within the septal myocar-
dium. Inclusion of blood pool or adjacent tissue should 
be carefully avoided. Motion correction is generally used 
to correct undesired breathing motion. However, motion 
correction can only correct for in-plane motion and not 
through-plane motion. All methods, therefore, are vul-
nerable to partial volume effects.
Demographic parameters
In one large study, there was no relationship of age to 
myocardial or blood native T1 in male subjects aged 
11–69  years [116]. In female subjects there was a trend 
of lower native T1 with increased age (e.g. approximately 
20  ms lower for females less than 45  years vs. those 
greater than 45  years) [116]. Female subjects < 45  years 
of age had a consistently higher native T1 then males, 
but after this age there was no difference in native T1 
by gender [116]. However, other studies have failed to 
demonstrate a significant trend in native T1 with age or 
gender [117]. For ECV measurement, ECV is reported to 
be higher in females than males, but data are conflicting 
regarding the relationship of ECV with age [110, 118].
The above relationships were formally assessed in a 
recent meta-analysis [101]. Overall, there was no signifi-
cant association between native T1 and age or percent of 
male participants at either 1.5 T or 3 T. However, there 
was a significant effect of gender with studies including 
more females on average having higher reported ECV 
values [101].
Studies included in this review
SCMR guidelines indicate each site should establish their 
own site specific reference ranges for T1 mapping param-
eters. In the absence of such data however, the weighted 
mean values and reference ranges for native T1 time and 
ECV based on publications of at least 40 healthy subjects 
extracted from Table 60 are summarized in Table 61.
Normal values of myocardial T2 relaxation times
CMR acquisition parameters
T2 relaxation time is the exponential time constant for 
the relaxation of transverse magnetization. To deter-
mine myocardial T2 time, a relaxation curve is con-
structed based on a CMR multi-echo pulse sequence. 
The most-commonly used technique utilizes a T2-prep-
aration module followed by either a single-shot bSSFP 
or GRE readout [150, 151]. This technique typically 
acquires 3 source images with effective echo times of 0, 
Fig. 15 T1 maps with measurements. T1 map pre‑ (a) and post‑contrast (b) with left ventricular endocardial and epicardial contours according to 
reference [119]
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30 and 60 ms. 3–4 heart-beats are allowed for T1 relaxa-
tion between acquisition of source images, and data is 
acquired during a single breath-hold of 9–12 heart-beats. 
Inadequate time for complete T1-relaxation between 
source images can cause a T1-based bias in the T2 maps. 
The bSSFP technique has higher signal-to-noise but is 
more susceptible to off-resonance artifacts than the GRE 
technique. Other techniques are based on turbo-spin 
echo (TSE) or GRadient And Spin Echo (GRASE) acqui-
sition modes. TSE sequences consist of a 90° excitation 
followed by a train of 180° refocusing pulses, with each 
focusing pulse producing a spin-echo with a different 
echo time (TE). By creating images corresponding to 
each echo time in the train, T2 maps can be produced by 
fitting the T2-signal decay equation. TSE sequences are 
robust to off-resonance, but they can suffer from inac-
curacies due to imperfect 180° pulses which result in 
stimulated-echo contamination. GRASE sequences con-
sist of a 90° excitation followed by a train of 180° pulses 
which produce a spin echo, and 2–4 gradient echoes. 
Table 60 References, native myocardial T1 relaxation time and extracellular volume fraction (ECV)
n number of study subjects, MOLLI modified look locker inversion‑recovery, ShMOLLI short MOLLI, T1 T1 relaxation time, ECV extracellular volume fraction
a Not provided in original publication
First author, year CMR technique n, male:female Age range 
or mean ± SD 
(years)
Fontana, 2012 [120] 1.5 T, Siemens, ShMOLLI, ECV 27:23 47 ± 17
Kellman, 2012 [121] 1.5 T, Siemens, MOLLI, native T1 and ECV 30:32 47 ± 17
Piechnik, 2013 [116] 1.5 T, Siemens, ShMOLLI, native T1 169:173 11–69
Sado, 2013 [122] 1.5 T, Siemens, ShMOLLI, native T1 30:37 24–88
Ferreira, 2014 [123] 1.5 T, Siemens, ShMOLLI, native T1 37:13 41 ± 13
Fontana, 2014 [124] 1.5 T, Siemens, ShMOLLI, native T1 17:35 46 ± 15
Liu, 2014 [125] 3 T, Siemens, MOLLI, native T1 38:54 27–44
Puntmann, 2014 [126] 3 T, Philips, MOLLI, native T1 47 (total) –a
Reiter, 2014 [118] 1.5 T, Siemens, MOLLI, native T1 20:20 20–35
aus dem Siepen, 2015 [127] 1.5 T, Philips, MOLLI, native T1 and ECV 37:19 52 ± 9
Banypersad, 2015 [128] 1.5 T, Siemens, ShMOLLI, native T1 and ECV 25:29 46 ± 15
Edwards, 2015 [129] 1.5 T, Siemens, MOLLI, native T1 and ECV 24:19 57 ± 10
Fontana, 2015 [130] 1.5 T, Siemens, ShMOLLI, native T1 and ECV 21:26 24–69
Treibel, 2015 [131] 1.5 T, Siemens, ShMOLLI, native T1 and ECV 26:24 28–69
Goebel, 2015 [132] 1.5 T, Siemens, MOLLI, native T1 31:23 18–63
Gormeli, 2016 [133] 3 T, Siemens, MOLLI, native T1 26:15 24 ± 4
Hinojar, 2016 [134] 3 T, Philips, MOLLI, native T1 9:37 42 ± 15
Ntusi, 2016 [135] 1.5 T, Siemens, ShMOLLI, native T1 53:39 44 ± 10
Rauhalammi, 2016 [136] 1.5 T and 3 T, Siemens, MOLLI, native T1 43: 41 45 ± 18
Costello, 2017 [137] 3 T, Siemens, ShMOLLI, native T1 and ECV 29:28 48 ± 15
Avitzur, 2018 [138] 3 T, Siemens, ShMOLLI, native T1 83:57 54 ± 9
Doerner, 2018 [139] 1.5 T, Philips, MOLLI, native T1 and ECV 30:20 39 ± 17
Guo, 2018 [140] 3 T, Philips, MOLLI, native T1 and ECV 18:32 36 ± 16
Ridouani, 2018 [141] 1.5 T, Siemens, MOLLI, native T1 20:20 40 ± 12
Rosmini, 2018 [142] 1.5 T, Siemens, MOLLI and ShMOLLI, native T1 and ECV 49:45 20–76
Shang, 2018 [143] 3 T, Siemens, MOLLI, ECV 45 (total) –a
Yang, 2018 [144] 3 T, Siemens, MOLLI, native T1 and ECV 18:26 33 ± 16
Granitz, 2019 [145] 1.5 T and 3 T, Philips, MOLLI, native T1 26:32 42 ± 13 
(male), 
40 ± 14 
(female)
Imran, 2019 [146] 1.5 T, Philips, MOLLI, native T1 26:25 46 ± 14
Lehmonen, 2019 [147] 1.5 T, Siemens, ShMOLLI, native T1 46 (total) 46 ± 9
Vijapurapu, 2019 [148] 1.5 T, Siemens, ShMOLLI, native T1 40:37 49 ± 14
Wan, 2019 [149] 3 T, Siemens, MOLLI, native T1 and ECV 20:20 56 ± 9
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This technique is more efficient than TSE but is subject 
to similar biases as the TSE technique, and additionally 
is more sensitive to off-resonance effects due to the pres-
ence of gradient echoes and longer spacing between 180° 
pulses. Of note, performing multiple TSE sequences with 
different effective-TEs are inaccurate for determining T2 
and are not recommended.
Factors affecting T2 relaxation time
There are a number of factors which can affect the meas-
urement of normal T2 values. Field strength has a small 
effect on T2 values, with 3  T scans typically having T2 
values that are ~ 6  ms shorter than those obtained on 
1.5 T scanners [152]. There are differences in measured 
T2 based on technical factors such as the type of pulse-
sequence used and the vendor. The T2-preparation pulse 
may be sensitive to off-resonance and B1 inhomogene-
ity effects; these effects are more severe at 3 T. T2-prep-
aration based on adiabatic radiofrequency (RF)-pulses 
have been shown to lessen these effects at 3 T. TSE and 
GRASE sequences are sensitive to specifics of the RF-
pulses which are vendor and implementation dependent. 
Similar to T1 mapping, it is imperative to standardize 
local pulse sequence parameters. As for T1 mapping, 
site-specific reference ranges should be established.
CMR analysis methods
T2 is the relaxation time (in milliseconds) of the trans-
verse magnetization. Similar to T1 assessment, to gener-
ate parametric maps of T2, the source images typically 
need to be aligned using non-rigid registration. Again, 
these techniques can correct  for in-plane motion but not 
through-plane motion. Both off-line and on-line tech-
niques have been used as for T1 mapping.
Demographic parameters
Published data on T2 values have sample sizes smaller 
than those of T1 methods. Thus, effects of demographic 
parameters in relationship to T2 times are not well 
established. One paper using GRASE demonstrated 
a slightly higher native T1 in females as compared to 
males (56.7  ms vs 54.6  ms; p = 0.008) at 1.5  T but no 
difference at 3  T. No significant differences in T2 were 
seen as a function of age [145]. Another study showed 
Table 61 Native myocardial T1 relaxation time and extracellular volume fraction (ECV)
ECV extracellular volume fraction, FS field strength, T Tesla, n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp 
pooled standard deviation, LL lower limit, UL upper limit, MOLLI modified look locker inversion‑recovery, ShMOLLI short MOLLI, Siemens Siemens Medical Solutions, 
Erlangen, Germany, Philips Philips Healthcare, Best, The Netherlands
a Pooled weighted values from references [118, 121, 129, 132, 136, 141, 142]
b Pooled weighted values from references [116, 122–124, 128, 130, 131, 135, 142, 147, 148]
c Pooled weighted values from references [127, 139, 145, 146]
d Pooled weighted values from references [125, 133, 136, 144, 149]
e Pooled weighted values from references [137, 138]
f Pooled weighted values from references [126, 134, 140, 145]
g Pooled weighted values from references [121, 129, 142]
h Pooled weighted values from references [124, 128, 130, 131, 142]
i Values from reference [127]
j Pooled weighted values from references [143, 144, 149]
k Values from reference [137]
l Pooled weighted values from references [139, 140]
m Calculated as  meanp ± 2*SDp
Parameter FS (T) Vendor Technique n Meanp SDp LL–UL
m
Native T1 time (ms) 1.5 Siemens MOLLI 417a 972 43 885–1059
1.5 Siemens ShMOLLI 971b 960 29 903–1017
1.5 Philips MOLLI 215c 989 42 905–1073
3 Siemens MOLLI 301d 1196 47 1103–1290
3 Siemens ShMOLLI 197e 1130 55 1021–1240
3 Philips MOLLI 201f 1097 66 964–1230
ECV (%) 1.5 Siemens MOLLI 199 g 26 3 20–32
1.5 Siemens ShMOLLI 295 h 27 3 21–33
1.5 Philips MOLLI 56i 23 3 17–29
3 Siemens MOLLI 129j 26 3 20–32
3 Siemens ShMOLLI 57 k 25 2 20–29
3 Philips MOLLI 100 l 26 5 16–36
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no difference between male and female subjects when 
controlling for age, but did see a trend of lower T2 with 
increasing age [153]. Another study using T2-prepared 
bSSFP at 3 T demonstrated no significant differences in 
T2 by age or gender [154].
Studies included in this review
SCMR guidelines indicate each site should establish their 
own site specific reference ranges for T2 mapping param-
eters. In the absence of such data however, the weighted 
mean values and reference ranges for T2 on publica-
tions of at least 40 healthy subjects (combined males and 
females) are shown in Table 62.
Normal values of myocardial T2* relaxation time
CMR acquisition parameters
Quantification of the T2* relaxation time plays an impor-
tant role for estimation of myocardial iron overload 
[156]. T2* time is also altered in myocardial necrosis and 
hemorrhage [102]. For quantification of the myocardial 
T2* time, the gradient-echo T2* technique with multiple 
increasing echo times is preferred over the spin-echo T2 
technique due to a greater sensitivity to iron deposition 
[157–159]. According to the current consensus state-
ment by the SCMR, a dark-blood multi-echo gradient 
echo sequence with 8 equally spaced echoes between 2 
and 18 ms should be used for T2*-mapping at 1.5 T [102]. 
Usually a single-breath hold technique is used. Normal 
values and a grading system for myocardial iron overload 
are available for 1.5 T [158].
CMR analysis methods
Gradient-echo T2* images are vulnerable to distortions 
of the local magnetic field e.g. by air-tissue interfaces. 
The myocardial septum is surrounded by blood on both 
sides, so susceptibility differences are less than in the 
lateral wall with improved image quality on T2* images. 
Therefore, T2* measurements are obtained by placing 
a region of interest on the interventricular septum of a 
midventricular short axis slice [102, 159] (Fig. 16).
T2* times are frequently reported as relaxation rate, 
representing the reciprocal of the time constant and cal-
culated as R2* = 1000/T2*. The units of R2* is  s−1 [159]. 
Cardiac iron concentration can be calculated from T2* 
values by the following equation: [Fe] = 45 / (T2*)1.22, 
where [Fe] is the cardiac iron concentration in milligrams 
per gram dry weight and T2* in milliseconds [160].
Table 62 Myocardial T2 relaxation time (ms)
FS field strength, T Tesla, n number of study subjects, SD standard deviation, LL lower limit, UL upper limit, T2P T2 preparation, bSSFP balanced steady state 
free precession, FLASH fast low angle shot, GSE gradient spin echo, Siemens Siemens Medical Solutions, Erlangen, Germany, Philips Philips Healthcare, Best, The 
Netherlands
a Calculated as mean ± 2*SD
First author, year FS (T) Vendor Technique n, male:female Age range or mean ± SD (years) Mean SD LL–ULa
Wassmuth, 2013 [155] 1.5 Siemens T2P bSSFP 60:13 20–70 55 5 45–65
Wassmuth, 2013 [155] 1.5 Siemens FLASH 60:13 20–70 52 5 42–62
Hinojar, 2016 [134] 3 Philips GSE 9:37 42 ± 15 45 4 37–53
Ridouani, 2018 [141] 1.5 Siemens T2P bSSFP 20:20 40 ± 12 51 3 45–57
Granitz, 2019 [145] 1.5 Philips GSE 26:32 40 ± 14 (male), 42 ± 13 (female) 56 3 50–62
Granitz, 2019 [145] 3 Philips GSE 26:32 40 ± 14 (male), 42 ± 13 (female) 52 3 46–58
Fig. 16 Measurements of myocardial T2* are obtained in the septum
Table 63 Grading of  iron overload based on  T2* 
measurements at 1.5T according to [102, 156, 162]
Iron overload T2* (ms)
Normal  > 20
Iron overload 10–20
Severe iron overload  < 10
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Demographic parameters
T2* of the myocardium is not related to age [161]. To our 
knowledge the relationship between other demographic 
parameters and T2* has not been assessed.
Studies included in this review
The mean T2* of the myocardium (interventricular sep-
tum) is approximately 36 ms [161] at 1.5 T using a multi-
echo GRE sequence. T2* > 20 ms is considered within the 
range of normal.
Depending on the risk to develop heart failure as a con-
sequence of myocardial iron overload, a grading system 
for disease severity has been published (Table  63) [102, 
156, 162].
Regional measurements and cardiac strain
CMR acquisition parameters
A number of imaging methods have been developed to 
acquire cardiac strain information from cine CMR. These 
methods include tagged cine CMR, PC-CMR, velocity 
encoded CMR, displacement encoding with stimulated 
echoes (DENSE), and strain-encoding (SENC) [163, 164]. 
Tagged CMR is a widely validated reproducible tool for 
strain estimation. The method is used in clinical studies 
and is considered the reference standard for assessing 
regional function [165, 166]. Recently feature-tracking 
CMR (FT-CMR) has been increasingly reported due to 
compatibility with existing cine CMR images [167].
CMR analysis methods
Cardiac strain is a dimensionless measurement of the 
deformation that occurs in the myocardium. Cardiac 
strain can be reported as three normal strains (circum-
ferential, radial, and longitudinal) and six shear strains—
the angular change between two originally mutually 
orthogonal line elements, with the more clinically inves-
tigated shear strain and the circumferential-longitudinal 
shear strain (also known as torsion). They can also be 
computed as fiber and cross-fiber strains which require 
anatomical knowledge of fiber architecture, or as prin-
cipal strains along the principal stretching and short-
ening directions [168]. Here, we concentrate on the 
widely reported circumferential and longitudinal strains. 
Although frequently reported, radial strain is less repro-
ducible because of the reduced resolution of imaging in 
the radial direction as opposed to the circumferential or 
longitudinal directions.
There are a number of different methods to quan-
tify strain: registration methods, feature-based tracking 
methods, deformable models, Gabor Filter Banks, optic 
flow methods, harmonic phase analysis (HARP) [169], 
and local sine wave modeling (SinMod) [163]. Technical 
review papers for these methods can be found in the fol-
lowing literature [167, 170–172].
Fig. 17 Illustration of strain computation using the Harmonic Phase (HARP) tool on tagged CMR images (a–d) and from feature tracking on 
cine CMR images (e–h). In HARP, first a semi‑automated frequency analysis of the tagged CMR image (a) is performed to identify the harmonic 
peaks in each of the tag directions (b), filters are then applied to isolate the peaks and obtain the corresponding phase maps from which Eulerian 
strain maps (c) can be computed. Subplot (d) shows the strain curve at the mid‑ventricular level for an asymptomatic volunteer obtained based 
on tracking of the user‑defined mesh (a). In feature tracking of cine CMR images, endo‑ and epicardial contours are drawn at end‑diastole (e) or 
end‑systole (g). A characteristic pixel pattern in the order of a few millimeters squared is identified as a template. The software then tries to discern 
a similar pattern in the subsequent frame from which displacement of the pixels is computed (f). This is repeated through the entire cycle to obtain 
displacement from which strain is computed. Subplot (h) shows the strain curve at the mid‑ventricular level computed from feature tracking. The 
tagged and cine CMR images and the strain curves were from the same participant
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HARP is one of the most widely reported and validated 
methods for analyzing tagged CMR for cardiac strain, in 
part due to its large scale use in the MESA study [169, 
173]. Strain patterns are reported according to the 16 or 
17 segment AHA  model. Consistent manual tracing of 
the endocardial and epicardial contours is necessary to 
reproducible strain results. With tagged CMR, midwall 
strain is preferred to epicardial and endocardial strain to 
maximize the amount of tagging data available for strain 
calculations [172, 174]. With HARP analysis such as that 
used in the MESA trial [169], careful selection of the first 
harmonic is necessary. Figure  17a shows an outline of 
tagged CMR analysis using HARP.
FT-CMR has shown diagnostic and prognostic util-
ity across a variety of pathologies. Currently, FT-CMR 
software from TomTec (TomTec Imaging Systems, 
Unterschleissheim, Germany), QStrain (Medis Medical 
Imaging Systems, Leiden, The Netherlands) and CVI42 
(Circle Cardiovascular Imaging Inc., Calgary, Canada) 
are widely used in clinical research for calculation of LV 
strains. Similar to tagged CMR from HARP, strains are 
reported in the 16 or 17 segment models.
Segmentation of the myocardium (either semi-auto-
mated or completely automated) at the start of the car-
diac cycle is an essential first step across all software. 
The software records a characteristic pixel pattern (an 
area of pixels typically in the order of 10–15  mm2) in the 
reference frame; an area with an identical pixel pattern 
is recognized in the next frame that maximizes certain 
similarity metrics [167, 175]. This procedure is repeated 
for all pixels in each image and for each frame to track 
the borders throughout the whole cardiac cycle with con-
straints for smoothness of the deformation field applied. 
FT-CMR tracking quality is largely governed by the qual-
ity and resolution of the pixels at the endocardial and 
epicardial borders which are feature-rich as compared to 
the mid-myocardium. This method has been extended 
to volume data by tracking voxels to obtain 3D FT-CMR 
[176]. Figure 17b shows an outline of the concept under-
lying strain analysis by FT-CMR.
Demographic parameters
Using both tagged CMR and FT-CMR, several studies 
report greater age is associated with decrease in peak 
circumferential or longitudinal shortening [176–178]. 
In tagged CMR and a few FT-CMR reports, gender also 
affects normal values. Cardiac strain values for women 
are higher than those of men [66, 176, 179–181]. How-
ever, some FT-CMR reports showed no association of 
circumferential or longitudinal strains with age or gender 
[26, 177].
Studies included in this review
Several studies have presented cohorts for determining 
normal LV  strain. For the purpose of this review, only 
cohorts of 40 or more normal subjects using SPAMM 
(spatial modulation of magnetization tagging) or FT-
CMR have been included. Inclusion criteria include a full 
description of the subject cohort (including the analysis 
methods used), age and gender of subjects. Table 64 rep-
resents a summary of publications reporting normal val-
ues for strain that fit the criteria. We have only included 
reference values for global values of strain as the inter-
reader and inter-study reproducibility of regional strain 
values vary widely between published reports.
With tagged CMR, normal midwall circumferential 
strain values are relatively comparable between studies 
[182, 183] (Table  65). With 2D FT-CMR, small differ-
ences between published results exist for reference val-
ues, probably due to inter-vendor differences [26, 66, 177, 
179]. The reference ranges of normal circumferential 
strains from FT-CMR (Table 66) are comparable to those 
obtained from tagged CMR (Table 65). Strain values are 
traditionally reported as more negative values mean-
ing greater contractility. For both global  circumferential 
and global longitudinal strain, a strain value of approxi-
mately -14% is the limit of normal; values more positive 
than this are considered to be abnormal.
Given the inclusion criteria noted above, one publica-
tion [176] used 3D FT-CMR (Table 67). The mean values 
and reference ranges were lower compared to 2D FT-
CMR and tagged-CMR.
Myocardial perfusion
Myocardial perfusion has been quantified with 
T1-weighted dynamic imaging during the first pass of a 
contrast bolus by semi-quantitative methods that derive 
dimensionless indices (e.g. the upslope of myocardial 
signal intensity changes during initial contrast enhance-
ment). Alternatively, absolute estimates of MBF may be 
determined (in units of ml per g of tissue and per minute 
(ml/g/min)). To derive absolute measures of blood flow, 
the CMR signal intensity changes must be converted to 
be linearly proportional to contrast concentration. This 
assumption may not hold true at high contrast concen-
trations (e.g. in the blood pool). Instead, low-dose bolus 
injections of contrast agent (e.g. < ~ 0.04  mmol/kg of 
Gd-DTPA) with saturation correction [184] or special 
pulse sequences are used for CMR perfusion (e.g. “dual-
sequence” [185], dual-bolus techniques [186, 187]) to 
provide linear measures of gadolinium concentration.
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Fig. 18 a The quantification of myocardial perfusion proceeds from the segmentation of images acquired during the first pass of contrast through 
the heart to delineate myocardial segments and a region in the center of the LV blood pool for the arterial input. This example shows one short‑axis 
image for a mid‑slice LV level. b For each myocardial segment one obtains a signal‑intensity versus time curve. A useful semi‑quantitative parameter 
for the assessment of the perfusion in a myocardial segment is the upslope, which is estimated from a fit to approximately 3–5 points during the 
initial myocardial contrast enhancement. c An analogous upslope parameter can be extracted from the first pass peak of the arterial input function. 
A perfusion index can be calculated from the ratio of the two upslopes as shown in the formula below (a), and accounts for some changes in the 
arterial input between rest and stress. d Absolute estimates of myocardial blood flow in ml/min/g can be obtained from the myocardial contrast 
enhancement curves and the arterial input function by fitting to a kinetic model for contrast enhancement, or, as done for this example, to estimate 
the myocardial impulse response by constrained deconvolution. Constraints are that the impulse response should be a monotonically decaying 
function of time, and requiring a relatively smooth, “regularized” impulse response. Myocardial blood flow (MBF) is estimated from the peak 
amplitude of the impulse response. e The ratio of myocardial blood flows during stress, divided by MBF at rest provides the most accurate estimate 
of the coronary flow reserve. In comparison, other ratios of perfusion indices (e.g. upslope index) for stress and rest systematically underestimate the 
flow reserve but may still prove useful for the detection of disease, assuming that one has established the normal range of the index.
Table 64 References, myocardial strain
n number of study subjects, SPAMM spatial modulation of magnetization, HARP harmonic phase, bSSFP balanced steady state free precession
a Mean ± SD (age‑range not provided in original publication)
b HARP commercial, Diagnosoft, Palo Alto, CA, USA
c TomTec Imaging Systems, Unterschleissheim, Germany
d CMI42, Circle Cardiovascular Imaging Inc., Calgary, Canada
e QStrain, Medis Medical Imaging Systems, Leiden, The Netherlands
First author, year CMR technique n, male:female Age range (years)
Neizel, 2009 [182] 1.5 T, 3 short axis images, tagged CMR (SPAMM), tagged resolution 7 mm; HARP  methodb 40:35 22–69
Augustine, 2013 [177] 1.5 T, short axis stack bSSFP, 2, 3, and 4 chamber bSSFP; feature tracking (TomTec 
 softwarec)
54:62 (30 ± 8)a
Venkatesh, 2015 [183] 1.5 T, 3 short axis images, tagged CMR (SPAMM), tagged resolution 7 mm, HARP  methodb 46:83 45–84
Andre, 2015 [179] 1.5 T, short axis stack, 2, 3, and 4 chamber bSSFP; feature tracking (TomTec  softwarec) 75:75 21–71
Cai, 2017 [66] 3 T, short axis stack, 2, 3, and 4 chamber bSSFP; feature tracking (CVI42  softwared, 2D) 91:89 20–69
Liu, 2018 [26] 1.5 T, short axis stack bSSFP, 2, 3, and 4 chamber bSSFP; feature tracking (CVIR42 
 softwared, 3D)
50:50 20–70
Peng, 2018 [176] 1.5 T and 3 T, short axis stack, 2, 3, and 4 chamber bSSFP; feature tracking (QStrain 
 softwaree)
75:75 18–82
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CMR acquisition parameters
Normal values for quantitative myocardial perfu-
sion measures have been obtained by ECG-gated, 
T1-weighted dynamic imaging during the first pass of an 
injected contrast bolus using gradient-echo image read-
outs without or with bSSFP. Echo-times are kept as short 
as possible for any of these image acquisition methods to 
minimize T2*-related signal loss. T1-weighting is gener-
ally maximized by using saturation-recovery magnetiza-
tion preparations. Semi-quantitative parameters depend 
on contrast dosage and injection protocol, sequence tech-
nique and acquisition parameters. The normal ranges for 
semi-quantitative parameters should therefore only be 
used as reference when the same protocol settings are 
employed. MBF (in units of mL/min/g) should be inde-
pendent of the specific perfusion imaging protocol set-
tings. However, a specific technique may still introduce a 
bias to under or over-estimate MBF.
In clinical use, myocardial perfusion imaging is gen-
erally performed at rest and during vasodilator stress. 
Adenosine and regadenoson are currently the most fre-
quently used pharmacological stress agents for myocar-
dial perfusion imaging and have supplanted dipyridamole 
in this role. Adenosine and regadenoson have similar 
hemodynamic effects on coronary  artery blood flow 
[188]. The choice of pharmacologic stress agent is mostly 
determined by considerations of patient comfort, safety 
and cost. Regadenoson is more expensive, but bet-
ter tolerated than adenosine. A unique application of 
myocardial perfusion imaging is its use in combination 
with the cold-pressor test to assess coronary endothelial 
function [189, 190].
CMR analysis methods
All quantitative approaches for CMR myocardial perfusion 
are based on signal-intensity versus time curves that depict 
the contrast enhancement during the first pass and recircu-
lation of an injected contrast bolus. The myocardial perfu-
sion images are segmented along the endo- and epicardial 
borders, and the ventricular wall is divided into segments 
following a standardized segmentation model for cardiac 
perfusion studies (Fig. 18).
The most widely used semi-quantitative parameter has 
been the up-slope parameter for initial myocardial contrast 
enhancement. Because the upslope derives from signal-
intensity curves with arbitrary units, the value of the up-
slope depends on the image acquisition settings and on the 
characteristics of the contrast bolus. For this reason, the 
myocardial up-slope parameter is generally normalized by 
the up-slope of the arterial blood pool of the LV to obtain 
a dimensionless perfusion index. This index is quantified 
during resting conditions and “stress” at maximal vasodi-
lation (i.e. hyperemia) after infusion of a pharmacological 
agent (e.g. adenosine). The coronary flow reserve is the 
ratio of the “stress” index, divided by “rest” index. We refer 
below to this parameter as the “up-slope” perfusion reserve.
Absolute quantification of the myocardial perfu-
sion reserve entails estimating MBF in ml/min/g. MBF 
Table 65 Left ventricular global peak circumferential 
strain using tagging
Pooled weighted values from references [182, 183]
n number of study subjects included in the weighted mean values, meanp 
pooled weighted mean, SDp pooled standard deviation, LL lower limit, UL upper 
limit
a Calculated as  meanp ± 2*SDp
Parameter n Meanp SDp LL–UL
a
Circumferential strain (%) 204  − 20.1 3.0  − 26.0 to − 14.2
Table 66 Left ventricular global peak circumferential and  longitudinal strain for  men and  women using 2D feature 
tracking
Pooled weighted values from references [66, 176, 177, 179]
n number of study subjects included in the weighted mean values, meanp pooled weighted mean, SDp pooled standard deviation, LL lower limit, UL upper limit
a Calculated as  meanp ± 2*SDp
Parameter Men Women
n Meanp SDp LL–UL
a n Meanp SDp LL–UL
a
Circumferential strain (%) 295  − 20.9 3.2  − 27.2 to − 14.6 301  − 22.7 3.3  − 29.2 to − 16.2
Longitudinal strain (%) 295  − 19.4 3.3  − 26.1 to − 12.7 301  − 21.4 3.6  − 28.7 to − 14.2
Table 67 Left ventricular global peak circumferential 
and  longitudinal strain using 3D feature tracking 
according to reference [26]
n number of study subjects, SD standard deviation, LL lower limit, UL upper limit
a Calculated as mean ± 2*SD
Parameter n Mean SD LL–ULa
Circumferential strain (%) 100  − 17.6 2.6  − 22.8 to − 12.4
Longitudinal strain (%) 100  − 14.6 2.7  − 20.0 to − 9.2
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quantification can be based on tracer-kinetic modeling, 
or by using a deconvolution technique that is based on 
Zierler’s central volume theorem [191]. In either case it 
is important to have an accurate depiction of the arte-
rial input of contrast to a myocardial region of interest, 
which in practice is approximated by the arterial contrast 
enhancement observed in the LV cavity. The myocardial 
perfusion reserve is estimated as “stress” MBF, divided by 
“rest” MBF. Nevertheless, hyperemic MBF by itself is also 
a useful measure of the maximal vasodilator response 
and its normal range is also provided by some studies in 
the literature. Rest MBF increases in proportion to the 
cardiac workload, and the rate-pressure product (RPP) is 
used as measure of cardiac workload to provide an RPP-
normalized MBF value (rest MBF/RPP), whose normal 
range is narrower in healthy persons than for the rest 
MBF without any adjustment for RPP.
Demographic parameters
In the CMR study by Wang et  al. [192], rest MBF was 
higher in women than in men; this agrees with previ-
ous studies in healthy  subjects using positron emission 
tomography [193]. Men have a lower hyperemic MBF 
compared to women, with adjustment for coronary heart 
disease risk factors [192]. Although male sex carries a 
higher risk for coronary heart disease, few studies of 
myocardial perfusion in healthy subjects have considered 
gender-related differences in MBF. The coronary flow 
response to the cold-pressor test is also higher in women 
compared to men [194].
Studies included in this review
There are two publications reporting reference val-
ues of absolute MBF at rest and under pharmacological 
stress with a sufficient sample size (> 40 healthy sub-
jects) (Table  68). The original study published by Wang 
et al. included subjects from the MESA population with 
comorbidities such as hypertension and diabetes [192]. 
However, for the purpose of this review, a re-analysis of 
[192] was performed for a subset of 99 healthy subjects 
of the cohort by one of the authors (MJH). Values are 
given for the entire cohort and for men and women sepa-
rately. In the other study by Brown et al. reference ranges 
are presented for the entire cohort of 42 healthy subjects 
[195]. Although in both studies images were acquired by 
means of a T1 weighted saturation recovery prepared 
Table 68 References, normal absolute myocardial blood flow at  rest and  stress and  perfusion reserve in  adults 
and children
n number of study participants, GRE gradient echo
a Analysis of a subset of healthy subjects (without hypertension, no use of antihypertensive or other medication for a cardiovascular condition, no diabetes, normal 
glucose tolerance, no smoking history and normal total cholesterol (< 240 mg/dl)) of the original cohort
b Median (interquartile range)
First author, year CMR technique n, male:female Age mean ± SD (years)
Wang, 2006 [192] a 1.5 T, T1weighted saturation recovery single‑shot GRE, at rest and under adenosine 
stress
49:50 59 ± 11
Madriago, 2015 [196] 3 T, T1weighted saturation recovery single‑shot GRE, at rest and under adenosine 
stress
11:9 8 ± 5
Brown, 2018 [195] 3 T, T1weighted saturation recovery single‑shot GRE, at rest and under adenosine 
stress
19:23 23 (22–29)b
Table 69 Reference ranges of  normal absolute myocardial blood flow (MBF)  at rest and  during  adenosine stress 
and perfusion reserve in adults and children
n number of study participants, MBF myocardial blood flow
a Ratio of MBF during stress divided by MBF at rest
b Calculated as mean ± 2*SD
c Data table was made available by senior author to calculate mean and SD
References n MBF at rest (ml/min/g) MBF during Adenosine stress (ml/min/g) Perfusion  reservea
Mean ± SD (LL–UL)b Mean ± SD (LL–UL)b Mean ± SD (LL–UL)b
Wang, 2006 [192] 99
49
50
All: 1.02 ± 0.24 (0.54–1.5)
Men: 0.96 ± 0.23 (0.5–1.96)
Women: 1.08 ± 0.23 (0.62–2.32)
All: 3.13 ± 0.80 (1.53–6.19)
Men: 2.79 ± 0.72 (1.35–5.49)
Women: 3.46 ± 0.73 (2.02–7.50)
All: 3.17 ± 0.87 (1.43–4.91)
Madriago, 2015 [196] c 20 0.94 ± 0.17 (0.6–1.28) 2.34 ± 0.82 (0.7–3.98) 2.63 ± 0.96 (0.71–4.55)
Brown, 2018 [195] 42 0.65 ± 0.13 (0.39–0.91) 2.71 ± 0.61 (1.49–3.93) 4.24 ± 0.69 (2.86–5.62)
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single-shot GRE sequences, normal reference ranges dif-
fer substantially. Therefore, in this review we abstained 
from calculation of weighted mean values and present 
reference ranges given in the two publications separately 
(Table 69).
There is a single study presenting reference ranges 
of myocardial perfusion in children [196] (Table  68). 
Although the sample size is small (n = 20) and children 
have cardiovascular pathologies (e.g. atrial and ventricu-
lar septal defects), data is presented here since a study of 
myocardial stress perfusion imaging in a larger subset of 
entirely healthy children seems not feasible (Table 68).
Artificial Intelligence (AI)-based segmentation 
methods for analysis of cine MRI
Currently no AI-based normal values have been pub-
lished in the literature. In recent years however, major 
improvements have been made in the development of 
automated CMR segmentation methods based on AI 
technology using so called Convolutional Neural Net-
works (CNN). Most published work report methods 
for automated LV and RV segmentation in Cine CMR 
[3, 197–203]. CNN based methods have also been pre-
sented for automated quantification of atrial dimensions 
[2, 204], myocardial scar tissue from LGE [205, 206], T1 
mapping [207], aortic flow [208] and disease classifica-
tion [209]. Given the potential importance of this topic to 
the field of CMR, this section summarizes relevant litera-
ture in this area and provides a summary of the publicly 
available CMR data sets relevant to AI segmentation of 
CMR data.
CNN-based automated image segmentation methods 
rely on training data, i.e. images with known segmen-
tation result, to derive a neural network with multi-
ple nodes, layers and weighting parameters that can be 
applied to unseen images to label every pixel in the 
image. The structure of the neural network varies among 
publications, but many are based on or are similar to 
the UNET structure introduced by Ronnenberger et  al. 
in 2015 [210]. The applicability of a CNN implemen-
tation is highly dependent on the data that was used to 
train the weights in the CNN. Ideally, the training data 
is representative for the data for which the CNN is to 
be used. Important considerations include the mix of 
pathologies, mix of CMR scanner vendors and variation 
in CMR acquisition parameters in the training set. Many 
published CCN methods for CMR image segmentation 
are based on data sets that have been made publicly avail-
able in the setting of so called challenges, i.e. competi-
tions in which participants are invited to develop the best 
segmentation algorithm for a given type of data [211]. 
Table 70 lists the most relevant public CMR Cine CMR 
data sets that have been used for this purpose.
Validation of CNN based segmentation methods is 
based on comparing the results of automated segmenta-
tion with manual results from a trained observer. Com-
monly used geometrical validation metrics include the 
Dice overlap, Haussdorf distance and average distance 
Table 70 Publicly available data sets that  have been used for  training and  testing for  automated segmentation 
algorithms of the left and right ventricle
n number of subjects, MICCAI Medical Image Computing and Computer Assisted Intervention, LVSC Left Ventricle Segmentation Challenge, STACOM Statistical Atlases 
and Computational Modelling of the Heart, RVSC Right Ventricle Segmentation Challenge, ACDC Automatic Cardiac Diagnosis Challenge
Data set Conference/source n Segmented structure Data description
MICCAI‑2009 [213] MICCAI 2009 45 Left ventricle Single center, single vendor
5 sub‑groups: healthy, hypertrophy, heart failure with infarction and 
heart failure without infarction
Data hosted on: https ://www.cardi acatl as.org/studi es/sunny brook 
‑cardi ac‑data/
LVSC‑2011 [214] STACOM‑2011 200 Left ventricle Multi center, multi‑vendor
Myocardial infarction
RVSC‑2012 [215] MICCAI 2012 48 Right ventricle Single center
Randomly selected clinical cases
ACDC‑2017 [198] MICCAI 2017 150 Left ventricle Single center, 2 scanners, 1 vendor
5 sub‑groups (Normal, post‑myocardial infarction, dilated cardiomy‑
opathy, hypertrophic cardiomyopathy, abnormal right ventricle)
KAGGLE‑2015 [216] KAGGLE 2015s annual 
data science bow
1100 Left ventricle Multi center, multi scanner
Mix of patient and volunteer scans
Only end‑diastolic and end‑systolic ground truth results provided. 
No gold standard segmentations available
Multiple sources Cardiac Atlas Project [217]  > 6500 Left ventricle Multi center, multi‑vendor
Asymptomatic subjects
Data acquired with gradient echo cine acquisition
Data hosted on: https ://www.cardi acatl as.org/studi es/mesa/
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between contours [198]. Additionally, derived quantita-
tive parameters from either automated or manual con-
tours can be compared. As manual analysis is subject to 
observer bias and variability it can only serve as surrogate 
gold standard. Some papers report the observer variabil-
ity of manual analysis in order to assess how the limits 
of agreement of an automated method compare with the 
limits of agreement within or between manual observers.
CNN-based image segmentation methods are being 
introduced in commercially available image analy-
sis software packages. The question arises whether 
results from such automated methods can be used 
Table 71 Recent studies describing fully automated LV or  RV segmentation algorithm based on  Convolutional Neural 
Networks (CNN)
Recent studies (> 2017) describing fully automated LV or RV segmentation algorithm based on Convolutional Neural Networks (CNN), which were validated either on 
publicly available data sets, or using lager (> 300 subjects) single‑center or multi‑center clinical patient cohorts. Segmentation is performed from short‑axis cine MR, 
except stated otherwise.
LV left ventricle, RV right ventricle, LA left atrium, RA right atrium, MI myocardial infarction, DCM dilated cardiomyopathy, HCM hypertrophic cardiomyopathy, PH 
pulmonary hypertension, DICE dice overlap metric, HD Hausdorff distance, JI Jaccard index, CLBR challenge leader board ranking, ACD average contour distance, 
MICCAI Medical Image Computing and Computer Assisted Intervention, LVSC Left Ventricle Segmentation Challenge, ACDC Automatic Cardiac Diagnosis Challenge.
Author, year Segmented structure Data used for training/validation Validation methods/remarks
Tran, 2017 [203] LV + RV LV: MICCAI‑2009 (n = 45)
RV: RVSC‑2012 (n = 45)
Validation: auto vs manual
Metrics: DICE, HD, ACD
Bai, 2018 [2] LV + RV





Validation: auto vs manual
Metrics: DICE, HD, APD
LV: EDV, ESV, EF, SV, CO, LV mass
RV: EDV, ESV, EF, CO
Bernard, 2018 [198] LV + RV ACDC‑2017 (n = 150) Nine methods compared
Validation: auto vs manual
Metrics: DICE, HD, CLBR
LV: EDV, ESV, EF, LV mass
RV: EDV, ESV, EF
Khened, 2018 [200] LV + RV KAGGLE‑2015 (n = 1140)
ACDC‑2017 (n = 150)
LVSC‑2011 (n = 200)
Validation: auto vs manual
Metrics: DICE, CLBR
Patient diagnosis
Tan, 2018 [201] LV LVSC‑2011 (n = 200)
KAGGLE‑2015 (n = 1140)
Validation: auto vs manual
Metrics: DICE, JI, HD
EDV, ESV
Tao, 2018 [3] LV Training: 400 subjects
Testing: 150 subjects
Multi‑center, multi‑vendor
Multiple patient categories: MI (n = 322), DCM 
(n = 168), HCM (n = 23), DCM (n = 23), PH 
(n = 10) other (n = 27), normal (n = 23)
Validation: auto vs manual
Metrics: DICE
EDV, ESV, EF, LV mass
Vigneault, 2018 [204] LV + RV from multiple views 53 subjects
HCM (n = 42), healthy (n = 21)
ACDC‑2017 (n = 150)
Validation: auto vs manual
Metrics: DICE
Backhaus, 2019 [212] LV + RV Evaluation of SuiteHEART software (Neosoft)
300 randomly selected patients used for validation
Single center
1.5 T and 3 T data
Validation: auto vs manual
LV: EDV, ESV, SV, EF, LV mass
RV: EDV, ESV, EF
Bhuva, 2019 [197] LV Training data: 599 subjects
Test data 110 patients, 5 disease categories: 
myocardial infarction (n = 32), LVH (n = 17), car‑
diomyopathy (n = 17), other pathology (n = 14), 
healthy volunteers (n = 30)
Multi‑center, multi‑vendor, 1.5 T + 3 T
Scan‑rescan data
Data availability:
https ://www.thevo lumes resou rce.com
Validation based on comparing scan‑rescan 
reproducibility of automated vs manual 
analysis
EDV, ESV, SV, EF, LV mass
Detectable change in EF
Curiale, 2019 [199] LV MICCAI‑2009 (n = 45)
Cardiac Atlas Project (n = 95)
Validation: auto vs manual
Metrics: DICE
EDV, ESV, EF, LV mass
Tong, 2019 [202] LV + RV ACDC‑2017 (n = 150) Validation: auto vs manual
Metrics: Dice, HD
LV: EDV, ESV, EF, LV mass
RV: EDV, ESV, EF
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interchangeably with results from manual image analy-
sis. Although CNN’s are designed to replicate the image 
segmentation performed by an expert observer, it is con-
ceivable that relevant differences may occur, especially in 
myocardial pathologies which were not well represented 
in the cohort that was used to train the CNN.
Studies included in this review
Table  71 lists 11 studies presenting CNN based image 
segmentation methods for automated analysis of CMR 
imaging data. Studies are included based on having either 
used a well described public data set for training and test-
ing, or a dataset of > 300 subjects selected according to a 
properly described inclusion protocol. Most published 
work have used publicly available datasets for train-
ing and testing of algorithms for LV [198–202, 204] or 
RV [198, 200, 202–204] segmentation in short-axis cine 
CMR. The use of public data sets for algorithm training 
and validation enables objective comparison of the per-
formance of the methods. Due to the relatively small size 
of training sets used and the limitation in variation in 
patient pathology, scanner manufactures, field strength 
and scanning protocol, it is uncertain how these meth-
ods perform on routine clinical CMR data. However, 
the above studies do convincingly demonstrate the high 
potential of CNN based image segmentation.
There are several studies for which AI methods were 
developed and applied to larger cohorts of subjects. Bai 
et  al. presented a CNN method that was trained on a 
large dataset of 4875 subject scans of the UK BioBank 
cohort [2]. This method provides automated segmenta-
tion and quantification of short-axis and long-axis cine 
CMR for all four heart chambers. It was shown that the 
method provides excellent segmentation results when 
applied to cases from the UK Biobank cohort. However, 
for application in clinical patients, the method demon-
strated sub-optimal performance. Retraining the net-
work by including additional cases of a clinical cohort did 
result in better results in patient data.
In the study of Tao et  al. multi-center, multi-vendor, 
multi-pathology data was used to train and test vendor 
specific CNNs and a mixed-vendor CNN [3]. The authors 
showed that the CNN trained using a mix of data from all 
centers, vendors and pathologies had the highest overall 
performance. This indicates that it is feasible to use the 
same optimally trained CNN across multiple centers, 
vendors and patient pathologies.
A retrospective clinical validation of a commercial 
image analysis software tool was presented by Backhaus 
et  al. [212]. In a randomly selected cohort of 300 CMR 
examination LV and RV parameters were automatically 
derived using a commercial software tool (SuiteHEART, 
NeoSoft, Pewaukee, Wisconsin, USA) incorporating 
CNN based image segmentation. The agreement between 
manual and automated LV parameter assessment was 
good (Bias in LV-EF: − 2.5% ± 5.9%), while for RV 
assessment the agreement was lower (Bias in RV EF: 
5.8% ± 9.6%). As expected, the agreement between man-
ual and automated analysis was lowest in cases of poor 
image quality and in patients with abnormal cardiac 
anatomy.
Bhuva et  al. used another approach to assess the per-
formance of CNN based image segmentation as com-
pared to manual analysis [197]. In their study a CNN LV 
segmentation method was trained on 599 subjects and 
tested on scan-rescan data of 110 patients with multiple 
pathologies. It was shown that automated image seg-
mentation yielded similar scan-rescan reproducibility as 
manual image analysis, which suggests that automated 
segmentation is a viable alternative to manual analysis in 
a clinical setting.
Conclusions
CMR enables quantification of various functional and 
morphological parameters of the cardiovascular system. 
Advantages of a quantitative evaluation are a better dif-
ferentiation between pathology and normal conditions, 
grading of pathologies, monitoring changes under ther-
apy, and evaluating prognosis and the possibility of com-
paring different groups of patients and normal subjects.
Hence, here we present an updated and expanded ver-
sion of the “normal value CMR review”. This review has 
provided reference values and factors affecting these 
parameters on current CMR techniques and sequences. 
Due to continuing publications in the field and new tech-
niques transferred from research tools into clinical prac-
tice existing reference ranges need to be updated and 
values for new techniques integrated.
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